KERALA MEDICAL SERVICES CORPORATION LTD., I and II Final-first notic… · EAR DROPS BP 10 ml Bottle 7. D25002 SURGICAL SPIRIT IP 500 ml Bottle 8. D14027 TURPENTINE LINIMENT IP 100

…………………………………………………………………………………………………………………………………………………………………………………………………….

KMSCL – e-tender fot the Procurement of Drugs for the year 2019-20 Page 1 of 78

KERALA MEDICAL SERVICES CORPORATION LTD., (Dept. of Health & Family Welfare, Govt. of Kerala)

Thycaud P.O., Thiruvananthapuram-14 Tele Fax No : 0471-2945647,

0471-2337353, 0471-2945646 Email id : [email protected] CIN-U24233KL2007SGC021616

Essential Drugs Division www.kmscl.kerala.gov.in No. KMSCL/DRG/ED/833/2018(1) Date : 22.01.2019

NOTICE

(DRUGS – CATEGORY I & II)

Sub :- KMSCL – E-tender for the Procurement of Drugs for the year 2019-20 – Technical Bid Evaluation – Defects noticed/status– Published – reg.

Ref :- 1. E-tender No. KMSCL/DRGED/I&II/RC/2018/014 Dated 21.11.2018.

2. Amendment notices no. KMSCL/DRG/ED/833/2018(1) dated 03.12.2018, 04.12.2018 and 10.12.2018.

Technical bids submitted in response to the e-tender refferred above for the

procurement of Drugs for the year 2019-20 were opened on 26.12.2018 and scrutinized.

The status is published below.

All the bidders are directed to verify the details of their offered items in the notice

published.

Complaints/ suggestions/ representations, if any, on this notice shall be submitted to

the Tender Inviting Authority in writing on or before 5pm on 31.01.2019.

Sl. No

Drug Code

Drug Name Strength Unit Defects noticed and Status

Bid No. 1 M/s. Southern Union Pharmaceuticals Kerala Pvt Ltd, Thrissur

1. D14030/12 CALAMINE LOTION IP 50 ml Bottle Submitted the required documents.

2. D03009 EXPECTORANT MIXTURE CONCENTRATED

Each 5ml contains:

Camphorated Opium

Tincture IP 66- 1.62 ml,

Tincture Ipecacuanha IP 66 -0.875

ml, Tincture

Urgenia IP 66

500ML Bottle

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


- 0.75ml, Aromatic Spirit of

Ammonia IP 66 -0.875ml, Chloroform IP 0.025 ml, Water QS,

Alcohol Content 40-

45% v/v.

3. D14024 LIQUID PARAFFIN IP 100 ml Bottle

4. D14042 MAGNESIUM SULPHATE PASTE BP 100 gm Bottle

5. D20013

MIXTURE CARMINATIVE CONCENTRATE (EACH 10 ML, CONTAINS: WEAK GINGER TINCTURE BP/IP-0.625 ML, AROMATIC SPIRIT OF AMMONIA IP-0.625 ML, PEPPERMINT SPIRIT BP-0.25 ML, CHLOROFORM IP- 0.019 ML, SODIUM BICARBONATE IP- 0.275 GM, COMPOUND CARDAMOM TINCTURE IP-3.0 ML, AQUA Q.S-10 ML, ALCOHOL CONTENT-20-26% V/V)

500 ml Bottle

6. D15008 SODIUM BICARBONATE EAR DROPS BP 10 ml Bottle

7. D25002 SURGICAL SPIRIT IP 500 ml Bottle

8. D14027 TURPENTINE LINIMENT IP 100 ml Bottle

9. D14040 WHITE SOFT PARAFFIN IP 50 gm Bottle

Bid No. 2 M/s. Verve Humancare Laboratories, Dehradun, Uttarakhand

1. D13017 DOBUTAMINE HCL INJ IP 50mg/ml 5 ml Amp

1) Market standing certificate

submitted is in “USP” instead of tendered specification for D13017- Dobutamine Hcl Inj IP 50mg/ml, 5ml amp.

2) Bid offer form (Anx II) submitted is in “IP/USP” instead of tendered

2. D01023 FENTANYL CITRATE INJ IP 50mcg/ml 2 ml Amp

3. D01010 MORPHINE SULPHATE INJ IP 15mg/ml 1 ml

Amp

4. D06003 NALOXONE INJ IP 400mcg/ml 1 ml Amp

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


5. D29005 NORADRENALINE STERILE CONCENTRATE IP

0.20% 2ml amp specification of “IP” for D13017- Dobutamine Hcl Inj IP 50mg/ml, 5ml amp.

6. D01007 PETHIDINE HYDROCHLORIDE INJ IP

50mg/ml 2ml Amp

Bid No. 3 M/s. Bharat Biotech International Ltd, Hyderabad

1. D21021/12

RABIES VACCINE HUMAN IP (CELL CULTURE- CHICK EMBRYO/VERO) WITH 1ML DILUENT, 2ML SYRINGE WITH NEEDLE 24G AND FILE FOR OPENING. (FOR INTRA DERMAL ROUTE OF ADMINISTRATION)

2.5 IU 1ml

Submitted the required documents.

Bid No. 4 M/s. AGIO Pharmaceuticals Ltd, Mumbai

1. D05018 CETIRIZINE SYRUP IP 5 mg/5ml 30ml Bottle Notary attested copy of Market standing Certificate not submitted for the following;

D05010- Cetirizine Tab IP 10 mg

D14035- Mupirocin Ointment IP 2%w/w, 5gm tube.

2. D05010 CETIRIZINE TAB IP 10 mg 1 No

3. D14032 FUSIDIC ACID CREAM IP 2% 10gm tube

4. D14035 MUPIROCIN OINTMENT IP 2%w/w 5gm tube

Bid No. 5 M/s. Serum Institute of India Pvt Ltd, Mumbai

1 D12022 ERYTHROPOETIN RECOMBINANT INJ 4000 IU Vial/PFS Submitted the required documents.

Bid No. 6 M/s. Midascare Pharmaceuticals Pvt Ltd, Mumbai

1 D03022 BUDESONIDE INHALER 100

mcg/puff 200 MD Notary attested details of qualifications of Technical Personals employed are not mentioned in the bid document submitted.

2 D03017 SALBUTAMOL INHALATION IP

100 mcg/puff 200 MD

Bid No. 7 M/s. Intas Pharmaceuticals Ltd, Ahmedabad

1 D01049 BACLOFEN TAB IP 10 mg 1 no Notary attested copy of Original manufacturing license in Form 25 No.G/162 & Form 28 No.G/53 are not submitted.

2 D13070 CARVEDILOL TAB IP 25 mg 1 No

3 D13045 CARVEDILOL TAB IP 6.25 mg 1 No

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


4 D17014 CLOZAPINE TAB IP 25 mg 1 No

5 D17015 CLOZAPINE TAB IP 100 mg 1 No

6 D07018 LEVETIRACETAM TAB IP 500 mg 1 No

7 D13033 METOPROLOL TAB IP 50 mg 1 No

8 D17020 OLANZAPINE TAB IP 5 mg 1 No

9 D17016 OLANZAPINE TAB IP 10 mg 1 No

10 D13056 PRAZOSIN TAB (EXTENDED RELEASE)

5 mg 1 No

11 D17037 RISPERIDONE TAB USP 1 mg 1 No

12 D17017 RISPERIDONE TAB USP 2 mg 1 No

13 D17019 SERTRALINE TAB IP 50 mg 1 No

14 D11001 TRIHEXYPHENIDYL TAB IP 2 mg 1 No

15 D12022 ERYTHROPOETIN RECOMBINANT INJ

4000 IU Vial/PFS

Bid No. 8 M/s. Aculife Healthcare Pvt Ltd, Ahmedabad

1 D02012 CIPROFLOXACIN INJ IP 2 mg/ml 100 ml Bottle 1) Notary attested copy of WHO-

GMP Certificate for the manufacture of external preparations (D04003- Lignocaine Hcl Gel IP 2%, 30 gm Tube) in license no. G/28/1221 not submitted.

2) Notary attested details of Technical Persons employed in Quality testing not submitted.

3) M/s. Aculife Healthcare Pvt Ltd is debarred by the Odisha State Medical Corporation Ltd Vide OrderNo.12726/OSMCL/QA/710/2018 dated 21.08.2018 for a

2 D18006 DEXTROSE INJ IP 25% 100 ml Bottle

3 D18003 DEXTROSE INJ IP 5% 500ml Bottle

4 D18004 DEXTROSE INJ IP 10% 500ml Bottle

5 D18007/12 ELECTROLYTE P (MULTI ELECTROLYTE IN D 5%) INJ

500ml Bottle

6 D12006 HYDROXY ETHYL STARCH IV INFUSION 6%

130kDa/0.4 500 ml Bottle

7 D04003 LIGNOCAINE HCL GEL IP 2% 30 gm Tube

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


8 D02076 LINEZOLID INJ 200 mg/100ml

300 ml bottle period of three successive years from the date of order.

4) D18009- Ringers Lactate Inj IP500ml supplied by M/s. Aculife Healthcare Pvt Ltd is debarred by the Odisha State Medical Corporation Ltd Vide OrderNo.12229/OSMCL/QA/709/2018 dated 10.08.2018 for a period of three successive years from the date of order.

5) D18002- Sodium Chloride & Dextrose Inj IP 0.9%+5%w/v 500ml supplied by M/s. Aculife Healthcare Pvt Ltd is debarred by the Odisha State Medical Corporation Ltd Vide OrderNo.12457/OSMCL/QA/710/2018 dated 16.08.2018 for a period of three successive years from the date of order.

9 D18010 MANNITOL INJ IP 20%w/v 100 ml Bot

10 D02025 METRONIDAZOLE INJ IP 5 mg/ml 100ml bottle

11 D02018 OFLOXACIN INFUSION IP 2 mg/ml 100ml bot

12 D04011 PROPOFOL INJ IP 1% w/v 50ml Vial

13 D18009 RINGERS LACTATE INJ IP 500ml Bottle

14 D18002 SODIUM CHLORIDE & DEXTROSE INJ IP

0.9%+5%w/v 500ml Bottle

15 D18017 SODIUM CHLORIDE INJ IP 0.90% 100 ml

16 D18001 SODIUM CHLORIDE INJ IP 0.9%w/v 500ml Bot

17 D18011 WATER FOR INJECTION IP 10 ml Amp

Bid No. 9 M/s. Biocon Limited, Bangalore

1 D12022 ERYTHROPOETIN RECOMBINANT INJ 4000 IU Vial/PFS

1. Notary attested copies of Market standing certificate and WHO-GMP certificate of M/s. Virchow Biotech Pvt Ltd not submitted.

2. Notary attested copy of audited Balance Sheet and Profit & Loss statement for 2015-16 not submitted.

2 D21031

INSULIN INJECTION BIPHASIC ISOPHANE IP 30:70 (30% soluble insulin and 70% isophane insulin)

40 IU /ml 10ml Vial

3 D21006 INSULIN INJECTION ISOPHANE IP 40 IU /ml 10ml Vial

4 D21005 INSULIN INJECTION SOLUBLE IP 40 IU /ml 10ml Vial

Bid No. 10 M/s. Indian Immunologicals Ltd, Hyderabad

1 D21021/12

RABIES VACCINE HUMAN IP (CELL CULTURE- CHICK EMBRYO/VERO) WITH 1 ML DILUENT,2ML SYRINGE WITH NEEDLE 24G AND FILE FOR OPENING.(FOR INTRA DERMAL ROUTE OF ADMINISTRATION)

2.5 IU 1ml

Tendered monograph specification not mentioned in Bid offer form (Anx II) submitted.

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


Bid No. 11 M/s. Gufic Biosciences Ltd, Mumbai

1. D02052 AZITHROMYCIN INJ 500 mg 10 ml Vial

1. Notary attested copy of Market Standing Certificate not submitted for D04021- Vecuronium Bromide Inj IP 10mg bearing license no G/122 G/64 & G/28/1499.

2. Notary attested copy of Market Standing Certificate not submitted for following items bearing license no G/28/1499;

D02052- Azithromycin Inj 500 mg 10ml vial

D12015- Tranexamic Acid Inj IP 500 mg/5ml, 5 ml Amp

D02027- Vancomycin IV Infusion IP 500 mg vial

D04020- Vecuronium Bromide Inj IP 4 mg vial

3. Performance Statement (Annexure-IV) submitted is not in the format as in the tender document and also not attested by Notary Public for all offered items.

4. Power of Attorney/ Resolution of Board submitted is not attested by Notary Public.

5. Pack size not mentioned in the bid offer form (Anx II) for D02052- Azithromycin Inj 500mg, 10 ml Vial.

6. Tendered monograph specification and pack size is not mentioned in the bid offer form (Anx II) for D12015- Tranexamic Acid Inj IP 500 mg/5ml, 5 ml Amp.

7. Tendered monograph specification not mentioned in

2. D12015 TRANEXAMIC ACID INJ IP 500 mg/5ml 5 ml Amp

3. D02027 VANCOMYCIN IV INFUSION IP

500 mg Vial

4. D04020 VECURONIUM BROMIDE INJ IP

4 mg Vial


10 mg Vial

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


bid offer form (Anx II) for the following;

D02027- Vancomycin IV Infusion IP 500mg.

D04020- Vecuronium Bromide Inj IP 4mg Vial

D04021- Vecuronium Bromide Inj IP 10mg Vial

D12015- Tranexamic Acid Inj IP 500 mg/5ml, 5 ml Amp

8. Notary attested copies of original manufacturing license in Form 28 no. G/64 and G/122 not submitted.

9. Notary attested copy of Product permit for D02052- Azithromycin Inj 500mg, 10 ml Vial & D12015- Tranexamic Acid Inj IP 500 mg/5ml, 5 ml Amp against Lic No G/28/1499 not submitted.

Bid No. 12 M/s. Virchow Biotech Pvt Ltd, Hyderabad

1. D21012 ANTI SNAKE VENOM (FREEZE DRIED) POLYVALENT INJ

10ml Vial 1. Tendered monograph

specification/strength not mentioned in the Market Standing Certificate and Bid Offer Form (Anx II) submitted for D21012- Anti Snake Venom (Freeze Dried) Polyvalent Inj 10ml Vial.

2. Notary attested copy of original manufacturing license in Form 25 no. 02/RR/AP/2004/V/R dated 27/12/2004 not submitted.

3. Notary attaested copy of original manufacturing license and renewal certificate of licence no. 51/RR/AP/2004/F/R dated 20/11/2004 not submitted.

2. D12019 LOW MOLECULAR WEIGHT HEPARIN INJ IP

40 mg/0.4ml Vial/PFS

Bid No. 13 M/s. Pfizer Ltd, Mumbai

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


1. D08003 DIETHYL CARBAMAZINE TAB IP

100 mg 1 No. 1) Notary attested copy of Product

permit and Market standing certificate for D13056- Prazosin Tab (EXTENDED RELEASE) 5mg not submitted.

2) Notary attested copy of Original manufacturing license in Form 28A for D05011- Prednisolone Tab IP 10mg not submitted.

3) Market standing certificate submitted does not substantiate three year market standing for the following;

D08003- Diethyl Carbamazine Tab IP 100 mg

D05011- Prednisolone Tab IP 10 mg

4) Tendered monograph specification not mentioned in the product permit and market standing certificate submitted for D05011- Prednisolone Tab IP 10 mg.

5) Notary attested copy of WHO-GMP certificate not submitted for license no. 544 & 545.

6) Details of batch no. not mentioned in the performance statement (Anx IV) submitted for the following;

D13056- Prazosin Tab (Extended Release) 5mg

D07008- Phenytoin Sodium Inj IP/BP/USP 50mg/ml, 2ml amp

D05011- Prednisolone Tab IP 10mg

7) Notary attested details of technical persons employed in manufacturing not submitted.

8) Details of technical persons employed in quality testing submitted is not attested by

2. D13056 PRAZOSIN TAB (EXTENDED RELEASE)

5 mg 1 No.

3. D07008 PHENYTOIN SODIUM INJ IP/BP/USP

50 mg/ml 2ml Amp

4. D05011 PREDNISOLONE TAB IP 10 mg 1 No.

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


Notary public.

9) Annual turn over statement for the last three years not submitted.

10) The validity of BG submitted as balance EMD (up to 13.06.2019) is less than that required (25.08.2019) as per tender condition.

Bid No. 14 M/s. Pure & Cure Healthcare Pvt Ltd, Delhi

1. D19006 ACETAZOLAMIDE TAB IP 250 mg 1 No

1) Notary attested copy of Product permit, market standing certificate and performance statement not submitted for D07019- Oxcarbazepine Tab IP 150mg.

2) Tendered monograph is not mentioned in the product permit and market standing certificate for D07009- Clobazam Tab IP 5mg.

2. D13071 CHLORTHALIDONE TAB IP 12.5 mg 1 No

3. D02011 CIPROFLOXACIN TAB IP 500 mg 1 No

4. D07009 CLOBAZAM TAB IP 5 mg 1 No

5. D17038 CLONAZEPAM TAB IP 0.5 mg 1 No

6. D07016 GABAPENTIN TAB IP 100 mg 1 No

7. D13033 METOPROLOL TAB IP 50 mg 1 No

8. D20032 ONDANSETRON TAB IP 4 mg 1 No

9. D07019 OXCARBAZEPINE TAB IP 150mg 1 no.

10. D20018 PANTOPRAZOLE INJ BP 40 mg 10 ml Vial

11. D17040 PROCHLORPERAZINE TAB IP 5 mg 1 No

12. D17037 RISPERIDONE TAB USP 1 mg 1 No


Bid No. 15 M/s. Dr. Reddy's Laboratories Ltd, Hyderabad

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


1. D14055 SALICYLIC ACID OINTMENT IP

6% 30gm Tube 1) Notary attested copy of WHO-

GMP Certificate for manufacturing unit license no. 68/RR/AP/97/F/R is not submitted.

2) Notary attested copy of Original

Manufacturing License in Form 25 not submitted for D14055- Salicylic Acid Ointment IP 6%, 30gm Tube.

2. D20036 SUCRALFATE SUSPENSION

1g/5ml 100 ml bottle

Bid No. 16 M/s. Sance Laboratories Pvt Ltd, Kerala

1. D02055 CEFIXIME TAB IP 200 mg 1 No 1) The firm has neither furnished

Earnest Money Deposit (EMD) as stipulated in the tender document nor any Documentary proof that the firm is registered with the Industries Department of the State of Kerala not submitted.

2) Tendered monograph specification not mentioned in the market standing certificate submitted for D02095- Cefuroxime Axetil Oral Suspension BP/USP 125mg/5ml, 30ml bottle.

2. D02057 CEFPODOXIME PROXETIL TAB IP

200 mg 1 No

3. D02034 CEFTRIAXONE INJ IP 1gm Vial

4. D02095 CEFUROXIME AXETIL ORAL SUSPENSION BP/USP

125 mg/5ml 30ml bottle

5. D02020 CEFUROXIME INJ IP 750 mg Vial

6. D02112 CEPHALEXIN ORAL SUSPENSION (DRY) IP 125 mg/5ml 60 ml Bottle

Bid No. 17 M/s. Zest Pharma, Indore

1. D02004 AMOXYCILLIN CAP IP 250 mg 1 No. 1. Notary attested copy of Market

standing certificate not submitted for D02007- Ampicillin Cap IP 250mg.

2. Tendered monograph specification not mentioned in the product permit, Market standing certificate and performance statement (Anx IV) submitted for D02093- Azithromycin Oral Suspension IP 200 mg/5ml.

2. D02005 AMOXYCILLIN CAP IP 500 mg 1 No.

3. D02007 AMPICILLIN CAP IP 250 mg 1 No.

4. D02041 AMPICILLIN CAP IP 500 mg 1 No.

5. D02093 AZITHROMYCIN ORAL SUSPENSION IP

200 mg/5 ml

30 ml. bottle.

6. D02031 AZITHROMYCIN TAB IP 500 mg 1 No.

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


7. D02112 CEPHALEXIN ORAL SUSPENSION (DRY) IP

125 mg/5 ml

60 ml. bottle

8. D02063 CIPROFLOXACIN+TINIDAZOLE TAB

500 mg+ 600 mg

1 No.

9. D02011 CIPROFLOXACIN TAB IP 500 mg. 1 No.

10. D08014 FLUCONAZOLE TAB IP 150 mg 1 No.

Bid No. 18 M/s. Ciron Drugs & Pharmaceuticals Pvt Ltd, Mumbai

1. D13062 ADENOSINE INJ IP 3 mg/ml 2ml amp 1. Monograph is different from

that of tendered in the Product permit submitted for the following;

D13017- Dobutamine Hcl Inj IP 50 mg/ml

D13016- Dopamine Hcl Inj IP/USP 40 mg/ml

D07011- Midazolam Inj IP 1 mg/ml

D22032- Thiamine Inj IP 100 mg/ml

D22059- Calcium and Vitamin D3 Tab IP Equivalent to elemental Calcium 500mg and Vitamin D3 250IU

D01028- Diclofenac Sodium Gel IP 1% w/w

D15027- Dorzolamide + Timolol Eye Drops IP 2 % + 0.5 %

D15071- Oxymetazoline Hydrochloride Nasal Solution (Paediatric ) IP 0.025% w/v

D14031- Clobetasole Propionate Cream IP 0.05%, 15gm Tube.

2. Tendered monograph specification not mentioned in the product permit submitted for the following;

2. D05005 ADRENALINE BITARTRATE INJ IP

1 mg/ml 1 ml Amp

3. D02091 AMIKACIN SULPHATE INJ IP 250 mg/2ml 2ml Vial

4. D13040 AMIODARONE STERILE CONCENTRATE IP

50 mg/ml 3 ml

5. D04007 ATROPINE SULPHATE INJ IP 0.6 mg/ml 1 ml Amp


7. D05004 BETAMETHASONE SODIUM INJ IP

4 mg/ml 1ml Amp

8. D15019 BIMATOPROST EYE DROPS 0.03% 3 ml

9. D15021 BRIMONIDINE EYE DROPS IP

0.20% 5 ml

10. D04030 BUPIVACAINE INJ IP 0.25% 20 ml Vial

11. D04031 BUPIVACAINE INJ IP 0.50% 20 ml vial

12. D15022 CARBOXY METHYL CELLUL OSE EYE DROPS IP

0.50% 10 ml

13. D14022 CHLORHEXIDINE MOUTH WASH IP

60 ml bottle

14. D05008 CHLORPHENIRAMINE MALEATE INJ IP

10 mg/ml 1 ml Amp

15. D14031 CLOBETASOLE PROPIONATE CREAM IP

0.05% 15gm Tube

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


16. D08021 CLOTRIMAZOLE MOUTH PAINT

1% 15 ml D15028- Dorzolamide Eye Drops IP 2% 5ml

D08030- Ketoconazole Cream BP 2%, 5gm tube

3. Tendered Monograph not specified in market standing certificate submitted for the following;

D14031- Clobetasole Propionate Cream IP 0.05%, 15gm tube


4. Monograph is different from that of tendered in the Market standing certificate submitted for the following;

D02091- Amikacin Sulphate Inj IP 250 mg/2ml, 2ml Vial

D07011- Midazolam Inj IP 1mg/ml, 5ml Vial

D22032- Thiamine Inj IP 100mg/ml, 2ml

5. Notary attested copy of Market standing certificate & Performance statement (Anx IV) not submitted for D22059- Calcium and Vitamin D3 Tab IP Equivalent to elemental Calcium 500mg and Vitamin D3 250IU.

17. D07007 DIAZEPAM INJ IP 5 mg/ml 2ml Amp.

18. D13017 DOBUTAMINE HCL INJ IP 50 mg/ml 5 ml Amp

19. D13016 DOPAMINE HCL INJ IP/USP 40 mg/ml 5 ml

20. D15027 DORZOLAMIDE + TIMOLOL EYE DROPS IP

2% + 0.5% 5 ml

21. D15028 DORZOLAMIDE EYE DROPS IP

2% 5 ml

22. D15029 FLUOROMETHOLONE EYE DROPS IP

0.10% 5 ml

23. D17013 FLUPHENAZINE DECANOATE INJ IP

25 mg 1ml Amp

24. D04019 GLYCOPYRROLATE INJ IP 0.2 mg/ml 1ml Amp

25. D15035 HYDROXY PROPYL METHYL CELLULOSE EYE DROPS

0.30% 10 ml

26. D03013 IPRATROPIUM NEBULISING SOLUTION 250mcg/ml 15 ml

27. D22016 IRON SUCROSE INJ USP 20 mg

elemental Iron/ml

5ml Amp

28. D04001 KETAMINE INJ IP 50 mg/ml 10 ml Vial

29. D08030 KETOCONAZOLE CREAM BP 2% 5gm tube

30. D01051 KETOROLAC TROMETHAMINE INJ IP 30 mg/ml 1 ml amp

31. D13063 LABETALOL INJ IP 5 mg/ml 4ml amp

32. D04003 LIGNOCAINE HCL GEL IP 2% 30 gm Tube.

33. D04029 LIGNOCAINE HCL INJ IP (FOR IV USE) 2% w/v 30 ml Vial

34. D16007 MAGNESIUM SULPHATE INJ IP 500 mg/ml 2ml Amp

35. D07011 MIDAZOLAM INJ IP 1 mg/ml 5 ml Vial

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code



37. D06014 N-ACETYL CYSTEINE INJ 1g 5 ml amp

38. D15042 NATAMYCIN OPTHALMIC SUSPENSION IP

5%w/v 5ml


0.20% 2 ml amp

40. D20014 ONDANSETRON INJ IP 2 mg/ml 2 ml Amp

41. D15071 OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTION (PAEDIATRIC ) IP

0.025% w/v 10 ML

42. D07008 PHENYTOIN SODIUM INJ IP/ BP/USP 50 mg/ml 2ml Amp

43. D12005 PHYTOMENADIONE (VITAMIN K1) INJ IP 10 mg/ml 1 ml Amp

44. D18015 POTASSIUM CITRATE SOLUTION

Potassium Citrate-1100 mg + Citric Acid-334 mg

200 ml

45. D06004 PRALIDOXIME INJ IP 1 gm Vial

46. D15052 PREDNISOLONE ACETATE EYE/EAR DROPS 1% 5 ml

47. D17041 PROCHLORPERAZINE INJ IP 12.5 mg/ml 1 ml amp

48. D05009 PROMETHAZINE INJ IP 25 mg/ml 2ml Amp

49. D15053 PROPARACAINE HCL OPHTHALMIC SOLUTION 0.50% 5 ml

50. D03059 SALBUTAMOL NEBULISER SOLUTION BP 5 mg/ml 15 ml

51. D15011 SALINE NASAL DROPS 0.65% w/v 15ml Bot

52. D03001 THEOPHYLLINE AND ETOPHYLLINE INJ

50.6 mg+ 169.4 mg 2 ml Amp.

53. D22032 THIAMINE INJ IP 100 mg/ml 2ml

54. D01011 TRAMADOL INJ 50 MG/ML 1 ml Amp

55. D12015 TRANEXAMIC ACID INJ IP 500 mg/5ml 5ml amp

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code



4 mg Vial


10 mg Vial

58. D15009 XYLOMETAZOLINE NASAL DROPS IP

0.1% w/v 10 ml Bottle

59. D16004 METHYLERGOMETRIN MALEATE INJ IP

200mcg/ ml 1ml Amp

60. D16001 OXYTOCIN INJ IP 5 IU/ml 1ml Amp

61. D16021 OXYTOCIN INJ IP 10 IU Amp

62. D04013 SUCCINYL CHOLINE CHLORIDE INJ IP

50 mg/ml 10ml Vial

63. D13031/12 AMLODIPINE TAB IP(FILM COATED)

5 mg 1 No

64. D13013 ATORVASTATIN TAB IP 10 mg 1 No

65. D22059 CALCIUM AND VITAMIN D3 TAB IP

Equivalent to elemental Calcium

500mg and Vitamin D3

250IU

1 No

66. D05018 CETIRIZINE SYRUP IP 5 mg/ 5ml 30 ml Bottle


68. D17035 CINNARIZINE TAB IP 25 mg 1 No

69. D13046 CLONIDINE TAB IP 100mcg 1 No

70. D13023 CLOPIDOGREL TAB IP 75 mg 1 No

71. D08039 CLOTRIMAZOLE CREAM IP 1% w/w 10gm Tube

72. D01028 DICLOFENAC SODIUM GEL IP 1% w/w 25gm Tube

73. D20007/ 12 DOMPERIDONE TAB IP (FILM COATED) 10 mg 1 No

74. D13032/ 12 ENALAPRIL MALEATE TAB IP(FILM COATED) 5 mg 1 No

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


75. D12002 FOLIC ACID TAB IP 5 mg 1 No

76. D19005 HYDROCHLOROTHIAZIDE TAB IP

25 mg 1 No

77. D08024 HYDROXYCHLOROQUINE TAB IP

200 mg 1 No

78. D13051 LABETALOL TAB IP 100 mg 1 No

79. D01014 MEFENAMIC ACID TAB BP 500 mg 1 No


81. D13065 NIFEDIPINE PROLONGED- RELEASE TAB IP

10 mg 1 No

82. D02080 NITROFURANTOIN TAB IP 100 mg 1 No

83. D20041 ONDANSETRON ORAL SOLUTION IP



85. D09007 OSELTAMIVIR CAP IP 75 mg 1 No

86. D01003 PARACETAMOL PAEDIATRIC SYRUP/SUSPENSION IP

125 mg/5ml 60ml Bottle

87. D05007 PHENIRAMINE MALEATE TAB IP 25 mg 1 No

88. D07001 PHENOBARBITONE TAB IP 30 mg 1 No

89. D07002 PHENOBARBITONE TAB IP 60 mg 1 No

90. D07004 PHENYTOIN SODIUM TAB IP 100 mg 1 No

91. D03024 SALBUTAMOL SYRUP IP 2 mg / 5ml 60ml Bottle

Bid No. 19 M/s. Overseas Healthcare Pvt Ltd, Phillaur

1. D08015 ALBENDAZOLE ORAL SUSPENSION IP 200 mg/5ml 10 ml Bottle

1. Tendered Monograph not specified in the product permit submitted for the following;

D08024- Hydroxy Chloroquine 2. D02093

AZITHROMYCIN ORAL SUSPENSION IP 200 mg/5 ml 30ml bottle

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


3. D02031 AZITHROMYCIN TAB IP 500 mg 1 No Tab IP 200 mg

D20015- Lactulose Solution USP 667 mg/ml, 100 ml

2. Tendered Monograph not specified in the market standing certificate submitted for the following;

D08024- Hydroxy Chloroquine Tab IP 200 mg

D02093- Azithromycin Oral Suspension IP 200 mg/5 ml, 30ml bottle

D20015- Lactulose Solution USP 667 mg/ml, 100 ml

D02075- Levofloxacin Tab IP 500 mg.

4. D08024 HYDROXY CHLOROQUINE TAB IP

200 mg 1 No

5. D20015 LACTULOSE SOLUTION USP 667 mg/ ml 100 ml

6. D02075 LEVOFLOXACIN TAB IP 500 mg 1 No

7. D02080 NITROFURANTOIN TAB IP 100 mg 1 No



200 ml

9. D05034 PREDNISOLONE TAB IP 5 mg 1 No


Bid No. 20 M/s. Reliance Life Sciences Pvt Ltd, Mumbai

1. D12022 ERYTHROPOETIN RECOMBINANT INJ 4000IU Vial/PFS Submitted the required documents.

Bid No. 21 M/s. ICPA Health Products Ltd, Mumbai

1. D14022 CHLORHEXIDINE MOUTH WASH IP

60 ml BOTTLE 1) Two items were offered by the bidder in the Bid offer form (Anx II) in excel format, while only one item is mentioned in the Bid offer form (Anx II) in pdf format.

As per tender clause no. 6.15.3,” Bid offer form (Annexure-II) in PDF format submitted online alone will be consideredfor bid evaluation. If any discrepancy found with excel format, details submitted in the PDF format will prevail.”

2) Pack size not mentioned in the bid offer form (Anx II) submitted for D14022- Chlorhexidine Mouth Wash IP, 60ml bottle

3) Nortary attested copy of

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


product permit for D14022- Chlorhexidine Mouth Wash IP, 60ml bottle submitted is in ‘BP’ instead of tendered monograph specification of ‘IP’.

Bid No. 22 M/s. Sanofi India Ltd, Mumbai

1. D07009 CLOBAZAM TAB IP 5 mg 1 No 1. Product permit submitted for

D07009- Clobazam Tab IP 5mg is in “BP” monograph instead of tendered monograph of “IP”.

2. Drug code wrongly mentioned in bid offer form (Anx II) for D12019- Low Molecular Weight Heparin Inj IP 40 mg /0.4 ml, Vial/PFS.

3. Tendered monograph not mentioned in the bid offer form (Anx II) for the following;

D12019- Low Molecular Weight Heparin Inj IP 40 mg /0.4 ml, Vial/PFS

D05007- Pheniramine Maleate Tab IP 25 mg.

2. D19001 FRUSEMIDE TAB IP 40 mg 1 No

3. D12019 LOW MOLECULAR WEIGHT HEPARIN INJ IP 40 mg /0.4 ml Vial/PFS

4. D05007 PHENIRAMINE MALEATE TAB IP 25 mg 1No

Bid No. 23 M/s. Sanofi Synthelabo (India) Pvt Ltd, Mumbai

1. D13023 CLOPIDOGREL TAB IP 75 mg 1No Submitted the required documents.

Bid No. 24 M/s. Hab Pharmaceuticals & Research Ltd, Mumbai

1. D09002/ 12 ACYCLOVIR TAB IP 400 mg 1 No 1. Tendered Monograph not

specified in product permit for the following;

D09002/12- Acyclovir Tab IP 400 mg D08001- Albendazole Tab IP 400 mg D17005- Amitriptyline Tab IP 25 mg D15022- Carboxy

2. D08001 ALBENDAZOLE TAB IP 400 mg 1 No

3. D17005 AMITRIPTYLINE TAB IP 25 mg 1 No

4. D15022 CARBOXY METHYLCELLUL OSE EYE DROPS IP 0.50% 10 ml

5. D15024 CIPROFLOXACIN +DEXAMETHASONE EAR DROPS

0.3%+ 0.1% 10 ml

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


6. D15002 CIPROFLOXACIN EYE/EAR DROPS IP

0.3%w/v 5ml Bottle Methylcellulose Eye Drops IP 0.50%, 10 ml D14031- Clobetasole Propionate Cream IP 0.05%,15gmTube D08014- Fluconazole Tab IP 150 mg D15041- Moxifloxacin Eye Drops IP 0.50%, 5 ml D14035- Mupirocin Ointment IP 2%w/w, 5gm tube D15005- Timolol Maleate Eye Drops IP 0.5%w/v, 5ml/Bot D21038- Voglibose Tab IP 0.2 mg

2. Strength is different in the product permit submitted for D15024- Ciprofloxacin +Dexamethasone Ear Drops 0.3%+ 0.1% from that of tendered.

3. Tendered monograph not mentioned in the market standing certificate submitted for the following;

D09002/12- Acyclovir Tab IP 400 mg D08001- Albendazole Tab IP 400 mg D17005- Amitriptyline Tab IP 25 mg

D15022- Carboxy Methylcellulose Eye Drops IP 0.50%, 10 ml

D08014- Fluconazole Tab IP 150 mg D21038- Voglibose Tab IP 0.2 mg

D17020- Olanzapine Tab IP 5mg


0.05% 15gm Tube


9. D17029 ESCITALOPRAM TAB IP 10 mg 1 No

10. D08014 FLUCONAZOLE TAB IP 150 mg 1 No

11. D17036 FLUOXETINE CAP IP 20 mg 1 No


13. D13053 LOSARTAN POTASSIUM TAB IP

50 mg 1 No

14. D15041 MOXIFLOXACIN EYE DROPS IP

0.50% 5 ml


16. D15046 OFLOXACIN EAR/EYE DROPS

0.30% 10 ml

17. D02017 OFLOXACIN TAB IP 200 mg 1 No

18. D17020 OLANZAPINE TAB IP 5 mg 1 No


20. D14036 PERMETHRIN CREAM 5% 30gm

21. D15005 TIMOLOL MALEATE EYE DROPS IP

0.5%w/v 5ml/Bot

22. D21038 VOGLIBOSE TAB IP 0.2 mg 1 No

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


D17016- Olanzapine Tab IP 10mg.

Bid No. 25 M/s. Malik Life Sciences Pvt Ltd, Delhi

1. D02036/

12

AMOXICILLIN AND POTASSIUM CLAVULANATE TAB IP

500 mg + 125 mg 1 No

1) Manufacturing license no. is wrongly mentioned in the Bid offer form (Anx II) as 48/UA/SC/2016 instead of 48/UA/SC/2013. 2. D02048

AMOXYCILLIN AND POTASSIUM CLAVULANATE ORAL SUSPENSION IP

Each 5ml contains;

400 mg + 57 mg

30 ml bottle

3. D02004 AMOXYCILLIN CAP IP 250 mg 1 No


5. D02041 AMPICILLIN CAP IP 500 mg 1 No

6. D02055 CEFIXIME TAB IP 200 mg 1 No

7. D02057 CEFPODOXIME PROXETIL TAB IP 200 mg 1 No

Bid No. 26 M/s. Appasamy Ocular Devices (P) Ltd, Himachal Pradesh

1. D15018

BALANCED SALT SOLUTION FOR OPHTHALMIC USE (GLASS BOTTLE/OT PACK)

500ml Bottle 1) Packing specification (Glass

bottle/OT Pack) not mentioned in the product permit for D15018- Balanced Salt Solution For Ophthalmic Use (Glass Bottle/OT Pack) 500ml Bottle.

2) Notary attested copy of Product permit and Market standing certificate not submitted for D15035- Hydroxy Propyl Methyl Cellulose Eye Drops 0.30%, 10ml.

3) Brand name only mentioned in the Market Standing Certificate submitted for the quoted items.

4) Performance statement submitted for all the items quoted is not in the tendered

2. D15022

CARBOXY METHYL CELLULOSE EYE DROPS IP 0.50% 10ml

3. D15029

FLUOROMETHOLONE EYE DROPS IP 0.10% 5 ml

4. D15030 FLURBIPROFEN EYE DROPS IP 0.03% 5 ml

5. D15035

HYDROXY PROPYL METHYL CELLULOSE EYE DROPS

0.30% 10 ml

6. D15036

HYDROXYPROPYL METHYL CELLULOSE OPHTHALMIC SOLUTION

2% 2 ml [PFS]

7. D15041

MOXIFLOXACIN EYE DROPS IP 0.50% 5 ml

8. D15044 NEPAFENAC OPHTHALMIC SUSPENSION 0.1% w/v 5ml

9. D15046

OFLOXACIN EAR/EYE DROPS 0.30% 10 ml

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


10. D15052

PREDNISOLONE ACETATE EYE/EAR DROPS

1% 5 ml format (Anx IV).

5) The firm has not furnished the balance EMD by way of DD/BG. The EMD submitted online by the bidder is not sufficient to cover that required for all the quoted products.


0.5%w/v 5ml/Bot

12. D15066 TOBRAMYCIN EYE/EAR DROPS

0.3% v/v 5 ml bottle

13. D15060

TROPICAMIDE + PHENYLEPHRINE OPHTHALMIC SOLUTION

0.8% + 5% 5 ml

14. D15006 TROPICAMIDE EYE DROPS IP 1%w/v 5ml

Bid No. 27 M/s. Medreich Ltd, Bangalore

1. D02036/12 AMOXICILLIN AND POTASSIUM CLAVULANATE TAB IP

500 mg + 125 mg

1 No 1) Notary attested copy of Product

permit not submitted for the quoted items. Only COPP attached.

2) Non-conviction certificate submitted is issued for participating in the tenders invited by Uttarpradesh Medical Supplies Corporation Ltd.

2. D02004 AMOXICILLIN CAP IP 250 mg 1 No

3. D02005 AMOXICILLIN CAP IP 500 mg 1 No

Bid No. 28 M/s. Fresenius Kabi India Pvt Ltd, Pune

1. D18003 DEXTROSE INJ IP 5% 500ml Bot Submitted the required documents.

2. D12006 HYDROXY ETHYL STARCH IV INFUSION 6% 130kDa/ 0.4 500 ml Bottle

3. D01035 PARACETAMOL INFUSION IP 1gm/ 100ml 100 ml bottle

4. D04010 PROPOFOL INJ IP 1% w/v 20ml Amp

5. D04011 PROPOFOL INJ IP 1% w/v 50ml Vial

6. D18009 RINGERS LACTATE INJ IP 500ml Bottle

7. D18002 SODIUM CHLORIDE & DEXTROSE INJ IP

0.9%+5%w/v 500ml Bottle

8. D18001 SODIUM CHLORIDE INJ IP 0.9%w/v 500ml Bot

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


Bid No. 29 M/s. Psychotropics India Ltd, Faridabad

1. D13013 ATORVASTATIN TAB IP 10 mg 1 No 1) Product permit and market

standing certificate submitted is in “BP” specification instead of tendered specification of “IP” for D19002- Frusemide Inj IP 10mg/ml, 2ml amp.

2) Tendered Monograph specification is not mentioned in the product permit and market standing certificate submitted for the following;



D05018- Cetirizine Syrup IP 5mg/5ml 30 ml Bottle

3) Product permit, market standing certificate and performance statement (Anx IV) submitted is for “Capsule” instead of tendered specification of D20021- Rabeprazole Gastro Resistant Tab IP 20mg.

4) License no. is wrongly mentioned in bid offer form (Anx II) as 41/UA/2006 instead of 41/UA/SC/P-2006 for D05021- Deflazacort Tab 6mg.

5) Details of 5 batches not mentioned in the performance statement (Anx IV) submitted for any of the quoted items.

6) Notary attested copy of Valid Market standing certificate not submitted for any of the quoted items.

2. D05017 BETAHISTINE TAB IP 8 mg 1 No

3. D07005 CARBAMAZEPINE TAB IP 200 mg 1 No

4. D02056 CEFOPERAZONE + SULBACTAM INJ

1gm+ 0.5gm

Vial




8. D17015 CLOZAPINE TAB IP 100 mg 1 No

9. D05021 DEFLAZACORT TAB 6 mg 1 No

10. D05001 DEXAMETHASONE INJ IP 4 mg/ml 2 ml Vial



13. D05037 FLUNARIZINE TAB 10 mg 1 No

14. D17036 FLUOXETINE CAP IP 20 mg 1 No

15. D19002 FRUSEMIDE INJ IP 10 mg/ml 2ml Amp

16. D21028 GLIMEPIRIDE TAB IP 1 mg 1 No

17. D21032/ 12

GLIMEPIRIDE TAB IP 2 mg 1 No

18. D05002 HYDROCORTISONE SODIUM SUCCINATE INJ IP

100 mg Vial


…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


20. D17025 LITHIUM CARBONATE TAB IP

300 mg 1 No


25 mg 1 No


50 mg 1 No

23. D21003 METFORMIN TAB IP 500 mg 1 No








30. D20033 PANTOPRAZOLE (GASTRO RESISTANT) TAB IP

40 mg 1 No


32. D17022 QUETIAPINE TAB IP 50 mg 1 No


34. D20021 RABEPRAZOLE GASTRO RESISTANT TAB IP

20 mg 1 No



37. D17019 SERTRALINE TAB IP 50 mg 1 No

38. D07006 SODIUM VALPROATE GASTRO RESISTANT TAB IP

200 mg 1 No


500 mg 1 No

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


40. D13061 TELMISARTAN TAB IP 40 mg 1 No

41. D12014 TRANEXAMIC ACID TAB IP 500 mg 1 No

Bid No. 30 M/s. Cadila Pharmaceuticals Ltd, Ahmedabad

1. D02004 AMOXYCILLIN CAP IP 250 mg 1 No Submitted the required documents.




5. D02031 AZITHROMYCIN TAB IP 500 mg 1 No

6. D02026 CEFOTAXIME SODIUM INJ IP

1gm Vial



elemental Iron/ml

5ml Amp



11. D01002 PARACETAMOL TAB IP 500 mg 1 No

12. D20001 RANITIDINE HCL INJ IP 50 mg /

2ml 2ml Amp

13. D20002 RANITIDINE HCL TAB IP 150 mg 1 No

Bid No. 31 M/s. Celon Laboratories Ltd, Hyderabad

1. D04023 ATRACURIUM BESYLATE INJ IP 10 mg/ml 2.5ml amp

1) Strength not mentioned in the bid offer form (Anx II) for D16002/12- Carboprost Tromethamine Inj IP 250 mcg/ml, 1ml vial/amp.

2) Pack size of the quoted items

2. D04030 BUPIVACAINE INJ IP 0.25% 20 ml Vial


…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


4. D13016 DOPAMINE HCL INJ IP/USP 40 mg/ml 5 ml are not mentioned in the product permit submitted.

3) Notary attested copy of Performance statement in Anx IV not submitted for the following;

D04011- Propofol Inj IP 1% w/v 50ml Vial

D12015- Tranexamic Acid Inj IP 500 mg/5ml, 5ml amp

D02027- Vancomycin IV Infusion IP 500 mg

D04021- Vecuronium Bromide Inj IP 10 mg

D16002/12- Carboprost Tromethamine Inj IP 250 mcg/ml, 1 ml Vial

3) WHO-GMP certificate not submitted for D06014- N-Acetyl Cysteine Inj 1g, 5ml amp

4) Monograph specification differ from that of tendered specification in the WHO-GMP certificate submitted for the following;

D04011- Propofol Inj IP 1% w/v, 50ml Vial

D16002/12- Carboprost Tromethamine Inj IP 250 mcg/ml, 1ml Vial/Amp.

5) The firm was blacklisted by Madhya Pradesh Public Health Service Corporation Limited (MPPHSCL) from 13.04.2018 to 12.04.2021 vide order no 1305/MPPHSCL/Technical/2018 dated 13.04.2018 on Quality grounds.

5. D04019 GLYCOPYRROLATE INJ IP 0.2 mg/ml 1ml Amp

6. D12003 HEPARIN SODIUM INJ IP 5000 IU/ml 5 ml Vial



40 mg/0.4 ml Vial/PFS


10. D04011 PROPOFOL INJ IP 1% w/v 50ml Vial

11. D12015 TRANEXAMIC ACID INJ IP 500 mg/5ml 5ml amp


500 mg Vial


10 mg Vial

14. D16002/ 12

CARBOPROST TROMETHAMINE INJ IP

250 mcg/ml 1ml Vial/Amp

Bid No. 32 M/s. Glaxo Smithkline Pharmaceuticals Ltd, Mumbai

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


1. D01013 ALLOPURINOL TAB IP 100 mg 1 No 1) Tendered monograph not

mentioned in the bid offer form (Anx II) for D21036- Thyroxine Sodium Tab IP 50mcg

2) Notary attested copy of Original Drug License in Form 28 & 25A not submitted.

3) Notary attested copy of Market standing certificate not submitted for D01013- Allopurinol Tab IP 100 mg.

4) Notary attested copy of WHO- GMP certificate for both the units not submitted.

5) Notary attested copy of Non-conviction certificate for M/s. Encore Healthcare Pvt Ltd, Aurangabad is not submitted.

6) The person authorised as Power of Attorney Holder of the firm and the person who signed declaration in Anx V is different.

2. D21036 THYROXINE SODIUM TAB IP 50 mcg 1 No

3. D21019 THYROXINE SODIUM TAB IP 100mcg 1 No.

Bid No. 33 M/s. Unicure India Ltd, Haridwar

1. D01019 ACECLOFENAC TAB IP 100 mg 1 No 1. Notary attested copy of Product

permit not submitted for the following;

D09002/12- Acyclovir Tab IP 400mg

D17007/12- Alprazolam Tab IP 0.25mg

D05010- Cetirizine Tab IP 10mg

2. Tendered monograph specification not mentioned in the product permit and market standing certificate submitted for D07009- Clobazam Tab IP 5mg.

3. Strength is different in the

2. D13036 ACETYL SALICYLIC ACID TAB IP(GASTRO-RESISTANT) 150 mg 1 No

3. D13024 ACETYLSALICYLIC ACID TAB IP(GASTRO-RESISTANT) 75 mg 1 No

4. D09002/12 ACYCLOVIR TAB IP 400 mg 1 No

5. D17007/12 ALPRAZOLAM TAB IP 0.25 mg 1 No

6. D13031/12 AMLODIPINE TAB IP(FILM COATED) 5 mg 1 No



…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


9. D05017 BETAHISTINE TAB IP 8 mg 1 No market standing certificate submitted for D22059- Calcium And Vitamin D3 Tab IP Equivalent to elemental Calcium 500mg and Vitamin D3 250IU.




250IU

1 No


12. D02063 CIPROFLOXACIN + TINIDAZOLE TAB

500 mg + 600 mg 1 No


14. D14031 CLOBETASOLE PROPIONATE CREAM IP 0.05% 15 gm Tube




18. D01004 DICLOFENAC SODIUM TAB IP(GASTRO-RESISTANT) 50 mg 1 No

19. D13004 DILTIAZEM TAB IP 30 mg 1 No

20. D20007/12 DOMPERIDONE TAB IP (FILM COATED) 10 mg 1 No

21. D02014/12 DOXYCYCLINE TAB USP 100 mg 1 No

22. D13032/12 ENALAPRIL MALEATE TAB IP(FILM COATED) 5 mg 1 No


24. D19001 FRUSEMIDE TAB IP 40 mg 1 No

25. D14032 FUSIDIC ACID CREAM IP 2% 10 gm Tube


27. D21032/12 GLIMEPIRIDE TAB IP 2 mg 1 No

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


28. D17010 HALOPERIDOL TAB IP 5 mg 1 No

29. D08024 HYDROXY CHLOROQUINE TAB IP

200 mg 1 No

30. D01031 INDOMETHACIN CAP IP 25 mg 1 No

31. D17033 LORAZEPAM TAB IP 2 mg 1 No


25 mg 1 No


50 mg 1 No

34. D16016 MEDROXY PROGESTERONE ACETATE TAB IP

10 mg 1 No




38. D06015 N-ACETYL CYSTEINE TAB 600 mg 1 No

39. D13065 NIFEDIPINE PROLONGED-RELEASE TAB IP

10 mg 1 No



42. D20004/12 OMEPRAZOLE (GASTRO RESISTANT) CAP IP

20 mg 1 No

43. D20011/12 ORS POWDER IP Single dose sachet

20.5 gm Packet



40 mg 1 No


125 mg/5 ml 60 ml bottle


…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


48. D14036 PERMETHRIN CREAM 5% 30 gm

49. D14011 POVIDONE IODINE SOLUTION IP

5% w/v 500 ml bottle

50. D25004 POVIDONE IODINE SOLUTION IP

7.50% 500 ml bottle



53. D20021 RABEPRAZOLE GASTRO RESISTANT TAB IP

20 mg 1 No

54. D13059 RAMIPRIL TAB IP 5 mg 1 No


56. D03004 SALBUTAMOL SULPHATE TAB IP

4 MG 1 No

57. D03024 SALBUTAMOL SYRUP IP 2 mg / 5 ml 60 ml bottle

58. D01041 SERRATIOPEPTIDASE TAB IP

10 mg 1 No


200 mg 1 No


500 mg 1 No

61. D20036 SUCRALFATE SUSPENSION 1g/5 ml 100 ml bottle


63. D03002 THEOPHYLLINE AND ETOPHYLLINE TAB

23 mg+77 mg

1 No

64. D12014 TRANEXAMIC ACID TAB IP 500 mg 1 No

65. D22002/12 VITAMIN B COMPLEX (STRONG) TAB

Each Tablet Containing

Nictonamide IP 20 mg, Pyridoxine

HCL IP 2 mg, Riboflavin IP

2 mg, Thiamine

HCL IP 5 mg

1 No

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


Bid No. 34 M/s. Samarth Lifescience Pvt Ltd, Mumbai

1. D01049 BACLOFEN TAB IP 10 mg 1 no Pack size are not mentioned in the product permit submitted for the following;

D04031- Bupivacaine Inj IP 0.50%, 20 ml vial

D22016- Iron Sucrose Inj USP 20 mg elemental Iron/ml, 5ml Amp

D13063- Labetalol Inj IP 5 mg/ml, 4ml amp

D06014- N-Acetyl Cysteine Inj 1g, 5 ml amp



elemental Iron/ml

5ml Amp




7. D06015 N-ACETYL CYSTEINE TAB 600 mg 1 No

8. D02027 VANCOMYCIN IV INFUSION IP 500 mg Vial

Bid No. 35 M/s. M J Biopharm Pvt Ltd, Mumbai

1. D21031

INSULIN INJECTION BIPHASIC ISOPHANE IP

30:70 (30% soluble insulin and 70% isophane insulin)

40IU/ml 10 ml vial

Tendered monograph specification not mentioned in the product permit, market standing certificate and performance statement (Anx IV) submitted for D01005- Diclofenac Sodium Inj IP 25mg/ml, 3ml amp.

2. D21006 INSULIN INJECTION

ISOPHANE IP 40IU/ml 10 ml vial

3. D21005 INSULIN INJECTION

SOLUBLE IP 40IU/ml 10 ml vial

4. D05005 ADRENALINE BITARTRATE

INJ IP 1 mg/ml 1ml Amp

5. D01005 DICLOFENAC SODIUM INJ IP 25 mg/ml 3ml Amp


7. D02026 CEFOTAXIME SODIUM INJ IP 1gm Vial


Bid No. 36 M/s. Chethana Pharmaceuticals, Kerala

1. D15041 MOXIFLOXACIN EYE DROPS IP 0.50% 5 ml

1. Tendered monograph specification not mentioned in

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code



0.3% v/v 5ml the bid offer form (Anx II), Product permit, Market standing certificate and performance statement (Anx IV) submitted for D15069- Dexamethasone Eye Drops BP 0.10%, 5ml.

2. Notary attested copy of original manufacturing license is not submitted.


0.5% w/v 5ml/bottle

4. D15046 OFLOXACIN EAR/EYE DROPS 0.30% 10ml

5. D15022 CARBOXY METHYLCELLULOSE EYE DROPS IP

0.50% 10ml

6. D15069 DEXAMETHASONE EYE DROPS BP 0.10% 5ml

7. D15030 FLURBIPROFEN EYE DROPS IP 0.03% 5ml

Bid No. 37 M/s. Nanz Med Science [P] Ltd, Himachal Pradesh

1. D14026/12 BENZYL BENZOATE APPLICATION IP 25% w/w 100 ml Bottle

1) Strength is wrongly mentioned in the bid offer form (Anx II) for D14026/12- Benzyl Benzoate Application IP25% w/w, 100 ml Bottle.

2) Tendered Monograph specification is different in bid offer form (Annexure II) for the following;

D14022- Chlorhexidine Mouth Wash IP 60 ml, Bottle

D01028- Diclofenac Sodium Gel IP 1% w/w, 25 gm Tube

D14035- Mupirocin Ointment IP 2% w/w, 5gm Tube

D25004- Povidone Iodine Solution IP 7.50%, 500ml bottle

D14001- Silver Sulphadiazine Cream IP 1% w/w, 100gm

D14001/12- Silver Sulphadiazine Cream IP 1% w/w, 500 gm

3) Product permit in “IP” specification not submitted for

2. D14022 CHLORHEXIDINE MOUTH WASH IP 60 ml Bottle

3. D08039 CLOTRIMAZOLE CREAM IP 1% w/w 10 gm Tube

4. D08021 CLOTRIMAZOLE MOUTH PAINT 1% 15 ml Bottle

5. D01028 DICLOFENAC SODIUM GEL IP 1% w/w 25 gm Tube

6. D04003 LIGNOCAINE HCL GEL IP

2%

30 gm Tube

7. D14041 MICONAZOLE CREAM IP 2% w/w 10 gm Tube

8. D14035 MUPIROCIN OINTMENT IP 2% w/w 5 gm Tube

9. D14036 PERMETHRIN CREAM

5%

30 gm Tube

10. D14043 POVIDONE IODINE OINTMENT USP 5% w/w 10 gm Tube

11. D14011 POVIDONE IODINE SOLUTION IP 5% w/v 500 ml Bottle

12. D25004 POVIDONE IODINE SOLUTION IP 7.50% 500 ml Bottle

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


13. D14001 SILVER SULPHADIAZINE CREAM IP

1% w/w 100 gm the following;

D25004- Povidone Iodine Solution IP 7.50%, 500ml bottle

D01028- Diclofenac Sodium Gel IP 1% w/w, 25gm tube

D14035- Mupirocin Ointment IP 2% w/w, 5gm Tube

4) Tendered monograph specification not mentioned in the market standing certificate submitted for D25004- Povidone Iodine Solution IP 7.50%, 500ml bottle.

5) Pack size not mentioned in the product permit submitted for the following;

D08021- Clotrimazole Mouth Paint 1%, 15ml bottle

D04003- Lignocaine Hcl Gel IP 2%, 30 gm Tube

D14043- Povidone-Iodine Ointment USP 5% w/w, 10gm tube

D14001/12- Silver Sulphadiazine Cream 1% w/w, 500 gm

6) The total EMD submitted by the bidder is not sufficient to cover that required for all the quoted products.

14. D14001/ 12

SILVER SULPHADIAZINE CREAM IP

1% w/w 500 gm

15. D14005 WHITFIELDS OINTMENT IP

15 gm

Tube

Bid No. 38 M/s. Shine Pharmaceuticals, Vadodara

1. D08015 ALBENDAZOLE ORAL SUSPENSION IP

200 mg/5ml 10 ml. bottle 1) Tendered Monograph is not

mentioned in the bid offer form (Anx II) submitted for the following;

D07009- Clobazam Tab IP 5mg

D07016- Gabapentin Tab IP

2. D08001 ALBENDAZOLE TAB IP 400 mg 1 No.

3. D17007/12 ALPRAZOLAM TAB IP 0.25 mg 1 No

4. D17005 AMITRIPTYLINE TAB IP 25 mg 1 No

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


5. D13013 ATORVASTATIN TAB IP 10 mg 1 No 100mg

D13029/12- Propranolol Tab IP 20mg

D17037- Risperidone Tab USP 1mg


2) Notary attested copy of original manufacturing license in Form 25 & Form 28 not submitted.

3) Notary attested copy of Product permit not submitted for the following;

D07009- Clobazam Tab IP 5mg

D07016- Gabapentin Tab IP 100mg

4) Notary attested copy of Market standing certificate not submitted for the following;


D13061- Telmisartan Tab IP 40 mg

5) Notary attested copy of Valid market standing certificate not submitted for the following;


D17025- Lithium Carbonate Tab IP 300mg


6) Notary attested copy of Performance statement in Anx IV not submitted for D17029- Escitalopram Tab IP 10mg.

6. D02093 AZITHROMYCIN ORAL SUSPENSION IP 200 mg/5 ml 30ml Bott.


8. D07005 CARBAMAZEPINE TAB IP 200 mg 1 No



11. D17001 DIAZEPAM TAB IP 5 mg 1 No





16. D17010 HALOPERIDOL TAB IP 5 mg 1 No


300 mg 1 No

18. D17033 LORAZEPAM TAB IP 2 mg 1 No

19. D17006 NITRAZEPAM TAB IP 5 mg 1 No




23. D13029/12 PROPRANOLOL TAB IP 20 mg 1 No


…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code



26. D17019 SERTRALINE TAB IP 50 mg 1 No

27. D07006 SODIUM VALPROATE GASTRO RESISTANT TAB IP 200 mg 1 No

28. D07023 SODIUM VALPROATE ORAL SOLUTION IP 200 mg/5ml 100 ml Bottle


30. D11001 TRIHEXYPHENIDYL TAB IP 2 mg 1 No

Bid No. 39 M/s. Alpa Laboratories Ltd, Indore

1. D02091 AMIKACIN SULPHATE INJECTION IP

250 mg/2ml 2ml Vial 1) Product permit and market

standing certificate submitted is for “150mg/ml” instead of tendered specification for D01009- Paracetamol Inj 150 mg/2ml, 2ml Amp.

2) Product permit submitted is for “BP” instead of tendered specification of “IP” for D01028- Diclofenac Sodium Gel IP 1% w/w, 25gm Tube.

3) Notary attested copy of Product permit not submitted for D14041- Miconazole Cream IP 2% w/w, 10gm Tube.

4) Market standing certificate submitted is for “USP” instead of tendered specification of “IP” for D02031- Azithromycin Tablets IP 500mg.

2. D02008 AMPICILLIN INJ IP

500 mg Vial


4. D04007 ATROPINE SULPHATE INJ IP 0.6 mg/ml 1 ml Amp


6. D02034 CEFTRIAXONE INJECTION IP 1gm Vial

7. D05008 CHLORPHENIRAMINE MALEATE INJ IP 10 mg/ml 1 ml Amp

8. D15024 CIPROFLOXACIN + DEXAMETHASONE EAR DROPS

0.3%+ 0.1% 10 ml


500 mg + 600 mg 1 No


0.3% w/v 5ml Bottle



13. D05001 DEXAMETHASONE INJ IP

4 mg/ml 2 ml Vial

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


14. D01028 DICLOFENAC SODIUM GEL IP

1% w/w 25gm Tube

15. D01005 DICLOFENAC SODIUM INJECTION IP

25 mg/ml 3 ml amp

16. D20009 DICYCLOMINE HCL INJ IP 10 mg/ml 2ml Amp

17. D19002 FRUSEMIDE INJECTION IP

10 mg/ml 2ml Amp

18. D02013 GENTAMICIN INJ IP

80 mg/2ml IM/IV VIAL


100 mg Vial

20. D04003 LIGNOCAINE HCL GEL IP

2% 30 gm Tube.

21. D04038 LIGNOCAINE HCL INJ IP (for IM use)

2% w/v 10 ml Vial


0.30% 10 ml

23. D14041 MICONAZOLE CREAM IP 2% w/w 10gm Tube

24. D01009 PARACETAMOL INJ

150 mg/2ml 2ml Amp.

25. D01008 PENTAZOCINE LACTATE INJ IP

30 mg/ml 1ml Amp.

26. D02039 PIPERACILLIN 4GM + TAZOBACTAM 500 MG INJ IP

4.5gm Vial

27. D14043 POVIDONE IODINE OINTMENT USP

5%w/w 10gm Tube


50.6 mg + 169.4 mg 2 ml Amp.


0.5%w/v 5ml/Bot

30. D01011 TRAMADOL INJ

50 MG/ML 1 ml Amp


500 mg Vial

32. D12001/12 VITAMIN B12/

CYANOCOBALA MIN INJ IP

100MCG/ml 2ml amp

Bid No. 40 M/s. Zim Laboratories Ltd, Nagpur

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


1. D01019 ACECLOFENAC TAB IP 100 mg 1 No Notary attested copy of Valid Renewal certificate of the manufacturing license is not submitted.



4. D13045 CARVEDILOL TAB IP 6.25 mg 1 No



500 mg + 600 mg

1 No







13. D03002 THEOPHYLLINE AND ETOPHYLLINE TAB

23 mg + 77 mg

1 No

Bid No. 41 M/s. Glenmark Pharmaceuticals Ltd, Mumbai

1. D17035 CINNARIZINE TAB IP 25 mg 1 No. 1) Notary attested copy of WHO-

GMP certificate and details of technical persons employed in Manufacturing and Quality Control sections in the manufacturing unit bearing Loan License no. DD/L/309 not submitted.

2) Non-conviction certificate for license no. DD/L/309 submitted is issued for participating in the tenders invited by DGAFMS, New Delhi.

2. D02098 CLINDAMYCIN + CLOTRIMAZOLE VAGINAL PESSARY

100 mg+200 mg 1 No.

3. D08008 CLOTRIMAZOLE VAGINAL PESSARIES IP 200 mg 1 No

4. D02076 LINEZOLID INJ 200 mg/ 100

ml 300 ml bottle

5. D02078 LINEZOLID TAB IP 600 mg 1 No


…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


Bid No. 42 M/s. Otsuka Pharmaceuticals India Pvt Ltd, Ahmedabad

1. D18003 DEXTROSE INJ IP 5% 500ml Bottle 1. Tendered monograph

specification not mentioned in the bid offer form (Anx II) for the following;

D18010- Mannitol Inj IP 20% w/v, 100ml Bottle

D02018- Ofloxacin Infusion IP 2 mg/ml, 100ml bottle

2. Notary attested copy of product permit for D18010- Mannitol Inj IP 20% w/v, 100ml Bottle not submitted.

3. Notary attested copy of performance statement in Annexure IV for D18003- Dextrose Inj IP 5% 500ml Bottle and D18007/12- Electrolyte P (Multi Electrolyte in D 5%) INJ, 500ml Bottle not submitted.

2. D18004 DEXTROSE INJ IP 10% 500ml Bottle

3. D18007/12 ELECTROLYTE P (MULTI ELECTROLYTE IN D 5%) INJ

500ml Bottle

4. D18010 MANNITOL INJ IP 20% w/v 100ml Bottle

5. D02025 METRONIDAZOLE INJ IP 5 mg/ml 100ml Bottle

6. D02012 CIPROFLOXACIN INJ IP 2 mg/ml 100ml Bottle


8. D18001 SODIUM CHLORIDE INJ IP 0.9%w/v 500ml Bottle

9. D18017 SODIUM CHLORIDE INJ IP 0.90% 100 ml

10. D18016 SALINE INJ 3% 100 ml

11. D18002 SODIUM CHLORIDE & DEXTROSE INJ IP

0.9% + 5% w/v

500ml Bottle

12. D02018 OFLOXACIN INFUSION IP 2 mg/ml 100ml Bottle

13. D18011 WATER FOR INJECTION IP 10ml Amp

Bid No. 43 M/s. Wipro GE Healthcare Pvt Ltd, New Delhi

1. D23001 IOHEXOL INJ USP 350 mg/ml 50ml 1) “USP” not mentioned in the bid

offer (Anx II) form for the following;

D23001- Iohexol Inj USP 350 mg/ml, 50ml

D23007- Iohexol Inj USP 350 mg/ml, 100ml bottle

2. D23007 IOHEXOL INJ USP 350 mg/ml 100ml Bottle

Bid No. 44 M/s. Maan Pharmaceuticals Ltd, Ahmedabad

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


1. D02049 AMOXYCILLIN AND

POTASSIUM CLAVULANATE INJ IP

1.2gm Vial 1) Tendered monograph

specification not mentioned in the Product permit and market standing certificate submitted for the following;

D02057- Cefpodoxime Proxetil Tab IP 200mg

D08026- Ivermectin Tab USP 6mg

D02039- Piperacillin 4gm + Tazobactam 500 mg INJ IP 4.5gm Vial

D02083- Piperacillin+ Tazobactam Inj IP 2gm + 250mg Vial

2) Tendered monograph specification not mentioned in the market standing certificate submitted for D02057- Cefpodoxime Proxetil Tab IP 200mg.


D20036- Sucralfate Suspension 1g/5ml, 100 ml bottle

D22026- Vitamin D3 Drops BP 400IU/ml, 15ml

4) Tendered monograph specification not mentioned in the Product permit submitted for D22026- Vitamin D3 Drops BP 400IU/ml, 15ml.

5) Notary attested copy of product permit submitted for D20036- Sucralfate Suspension 1g/5ml, 100 ml bottle is “For Export Only”.

6) Details of 5 batches not mentioned in the Performance Statement (Anx IV) submitted for the following;

2. D02056 CEFOPERAZONE

+ SULBACTAM INJ 1gm+ 0.5gm Vial

3. D02057 CEFPODOXIME

PROXETIL TAB IP 200 mg 1 No

4. D03034 COUGH SYRUP

Each 5 ml contains: Ambroxol HCL- 15

mg, Guiphenesin

- 50 mg , Terbutaline Sulphate- 1.25 mg , Menthol- 2.5 mg,

Flavoured syrupy base

q.s

50 ml Bottle

5. D22006 FERROUS SULPHATE TAB IP 200 mg 1 No


elemental Iron/ml

5ml Amp

7. D08026 IVERMECTIN TAB USP 6 mg 1 No


9. D20041 ONDANSETRON ORAL

SOLUTION IP 2 mg/5ml 30ml bottle

10. D20011/

12 ORS POWDER IP Single

dose sachet 20.5 gm Packet

11. D02039 PIPERACILLIN 4GM +

TAZOBACTAM 500 mg INJ IP 4.5gm Vial

12. D02083 PIPERACILLIN+

TAZOBACTAM INJ IP 2gm + 250 mg Vial

13. D20036 SUCRALFATE SUSPENSION 1g/5ml 100 ml bottle

14. D01011 TRAMADOL INJ 50 MG/M

L 1 ml Amp

15. D22020 VITAMIN C TAB IP 500 mg 1 No

16. D22026 VITAMIN D3 DROPS BP 400IU/ml 15ml

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


17. D22024 ZINC SULPHATE DISPERSIBLE TAB IP

20 mg elemental

Zinc 1 No

D20036- Sucralfate Suspension 1g/5ml, 100 ml bottle


Bid No. 45 M/s. Biological E Ltd, Hyderabad

1. D12003 HEPARIN SODIUM INJ IP 5000 IU/ml 5 ML VIAL Product permit submitted for D21009- Tetanus Toxoid Inj IP 10 Dose, 5ml Vial is not attested by Notary public.

2. D21009 TETANUS TOXOID INJ IP 10 DOSE 5 ML VIAL

Bid No. 46 M/s. FDC Limited, Mumbai

1. D01019 ACECLOFENAC TAB IP 100 mg 1 No 1) Tendered monograph

specification not mentioned in the bid offer form (Anx II) for D15021- Brimonidine Eye Drops IP 0.20%, 5ml.

2) Notary attested copy of Market standing certificate not submitted for D15044- Nepafenac Opthalmic Solution 0.1%w/v, 5ml.

3) Tendered monograph specification not mentioned in the product permit and market standing certificate submitted for the following;

D01019- Aceclofenac Tab IP 100mg

D17035- Cinnarizine Tab IP 25 mg

4) Tendered monograph specification not mentioned in the product permit submitted for the following;

D09002/12- Acyclovir Tab IP 400mg

D15021- Brimonidine Eye Drops IP 0.20%, 5ml

D15041- Moxifloxacin Eye



4. D15021 BRIMONIDINE EYE DROPS IP 0.20% 5 ml

5. D15022 CARBOXYMETHYL CELLULOSE EYE DROPS IP 0.50% 10 ml


7. D17035 CINNARIZINE TAB IP 25 mg 1 No

8. D15002 CIPROFLOXACIN EYE/EAR DROPS IP 0.3%w/v 5mlBottle


10. D15027 DORZOLAMIDE + TIMOLOL EYE DROPS IP 2% + 0.5% 5 ml

11. D15028 DORZOLAMIDE EYE DROPS IP 2% 5 ml



14. D15029 FLUOROMETHOLONE EYE DROPS IP 0.10% 5 ml

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


15. D15030 FLURBIPROFEN EYE DROPS IP

0.03% 5 ml Drops IP 0.50%, 5ml.

5) Performance statement in Annexure IV submitted is not attested by Notary public.

6) Notary attested copy Performance statement not submitted for the following;

D15022- Carboxymethyl Cellulose Eye Drops IP 0.50%, 10ml

D15029- Fluorometholone Eye Drops IP 0.10%, 5ml


16. D15035 HYDROXY PROPYL METHYL CELLULOSE EYE DROPS

0.30% 10 ml

17. D13011 LOSARTAN POTASSIUM TAB IP 25 mg 1 No



20. D15044 NEPAFENAC OPHTHALMIC SUSPENSION 0.1%w/v 5ml

21. D15046 OFLOXACIN EAR/EYE DROPS 0.30% 10 ml

22. D20011/12 ORS POWDER IP Single dose

sachet 20.5 gm Packet


24. D15005 TIMOLOL MALEATE EYE DROPS IP 0.5%w/v 5ml/Bot

Bid No. 47 M/s. Bharat Parenterals Ltd, Vadodra

1. D02036/12 AMOXICILLIN AND POTASSIUM CLAVULANATE TAB IP

500 mg +125 mg

1 no. 1) Drug code is wrongly

mentioned in the bid offer form (Anx II) for

D02017- Ofloxacin Tab IP 200 mg

D12003- Heparin Sodium Inj IP 5000IU/ml, 5ml vial

2) Tendered Monograph specification not mentioned in the bid offer form (Anx II), Product permit, Market standing certificate and performance statement (Anx IV) submitted for the following;

D20018- Pantoprazole Inj BP 40 mg, 10ml vial

D07008- Phenytoin Sodium Inj IP/BP/USP 50 mg/ml, 2ml amp

2. D02049 AMOXYCILLIN AND POTASSIUM CLAVULANATE INJ IP

1.2gm vial

3. D02048 AMOXICILLIN AND POTASSIUM CLAVULANATE ORAL SUSPENSION IP

Each 5ml contains: 400

mg+57 mg 30ml bottle

4. D02004 AMOXICILLIN CAP IP 250 mg 1 no.

5. D02005 AMOXICILLIN CAP IP 500 mg 1 no.

6. D07005 CARBAMAZEPINE TAB IP 200 mg 1 no.

7. D02055 CEFIXIME TAB IP 200 mg 1 no.

8. D02056 CEFOPERAZONE + SULBACTAM INJ 1gm+ 0.5gm Vial

9. D02026 CEFOTAXIME SODIUM INJ IP 1gm vial

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


10. D02057 CEFPODOXIME PROXETIL TAB IP

200 mg 1 no. D12005- Phytomenadione (Vitamin K1) Inj IP 10 mg/ml, 1ml amp

D02039- Piperacillin 4 Gm + Tazobactam 500 mg INJ IP 4.5gm vial

3) Tendered monograph specification not mentioned in the Market Standing Certificate submitted for D12015- Tranexamic Acid Inj IP 500mg/5ml, 5ml amp

4) Performance Statement in Anx IV submitted is not attested by Notary public.

5) Details of technical person employed in manufacturing unit is not attested by Notary public.

6) Details of manufacturing units in Annexure VII submitted are not attested by Notary public.

11. D02034 CEFTRIAXONE INJ IP 1gm vial

12. D02020 CEFUROXIME INJ IP 750 mg vial

13. D02011 CIPROFLOXACIN TAB IP 500 mg 1 no.

14. D14032 FUSIDIC ACID CREAM IP 2% 10gm tube

15. D12003 HEPARIN SODIUM INJ IP 5000IU/ml 5ml vial

16. D20015 LACTULOSE SOLUTION USP 667 mg/ml 100ml

17. D05028 METHYLPREDNISOLONE SODIUM SUCCINATE INJ USP

1gm vial

18. D02017 OFLOXACIN TAB IP 200 mg 1 no.

19. D20018 PANTOPRAZOLE INJ BP 40 mg 10ml vial

20. D07008 PHENYTOIN SODIUM INJ IP/BP/USP 50 mg/ml 2ml amp.

21. D12005 PHYTOMENADIONE (VITAMIN K1) INJ IP 10 mg/ml 1ml amp.

22. D02039 PIPERACILLIN 4 gm + TAZOBACTAM 500 mg INJ IP

4.5gm vial

23. D14043 POVIDONE IODINE OINTMENT USP 5% w/w 10gm tube

24. D15011 SALINE NASAL DROPS 0.65% w/v 15ml bot.

25. D15066 TOBRAMYCIN EYE/EAR DROPS 0.3%v/v 5ml bottle

26. D01011 TRAMADOL INJ 50 mg/ml 1ml amp.

27. D12015 TRANEXAMIC ACID INJ IP 500 mg/5ml 5ml amp.

28. D02027 VANCOMYCIN IV INFUSION IP 500 mg vial

Bid No. 48 M/s. Cipla Ltd, Mumbai

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


1. D15014 ACYCLOVIR EYE OINTMENT IP

3% 5gm Tube

1) Tendered monograph specification and dosage form is not mentioned for any of the quoted items in the bid offer form (Anx II).

2) Strength mentioned in the product permit for the following items are different from that of tendered;

D15070- Moxifloxacin Eye Ointment 5%w/w, 5 gm tube.

D03025- Budesonide Nebulising Solution 0.5mg/ml, 2ml respules.


D13040- Amiodarone Sterile Concentrate IP 50mg/ml, 3ml

D07018- Levetiracetam Tab IP 500 mg

D03059- Salbutamol Nebuliser Solution BP 5 mg/ml, 15 ml

4) Tendered monograph specification not mentioned in the market standing certificate submitted for the following;


D13064- Nebivolol Tab IP 5mg

D13059- Ramipril Tab IP 5 mg

D07006- Sodium Valproate Gastro Resistant Tab IP 200 mg

5) Market standing certificate not submitted for the following;

D02076- Linezolid Inj 200 mg/100 ml, 300 ml bottle

2. D13040 AMIODARONE STERILE CONCENTRATE IP

50 mg/ml 3 ml

3. D03022 BUDESONIDE INHALER 100 mcg/puff 200 MD

4. D03025 BUDESONIDE NEBULISING SOLUTION

0.5 mg/ml 2ml respules

5. D15024 CIPROFLOXACIN +

DEXAMETHASONE EAR DROPS

0.3%+ 0.1% 10 ml

6. D16009 CLOMIPHENE CITRATE TAB

IP 50 mg 1 No

7. D07018 LEVETIRACETAM TAB IP 500 mg 1 No


9. D02076 LINEZOLID INJ 200 mg/100

ml 300 ml bottle


11. D15070 MOXIFLOXACIN EYE

OINTMENT 5%w/w 5 gm tube

12. D13064 NEBIVOLOL TAB IP 5 mg 1 No

13. D20041 ONDANSETRON ORAL

SOLUTION IP 2 mg/5ml 30ml bottle


15. D03017 SALBUTAMOL INHALATION

IP 100 mcg/puff 200 MD

16. D07006 SODIUM VALPROATE

GASTRO RESISTANT TAB IP 200 mg 1 No


18. D15060 TROPICAMIDE + PHENYLEPHRINE

OPHTHALMIC SOLUTION 0.8% + 5% 5 ml


20. D03013 IPRATROPIUM NEBULISING SOLUTION 250mcg/ml 15 ml

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


21. D01053 PREGABALIN TAB 75 mg 1 No

D20041- Ondansetron Oral Solution IP 2mg/5ml, 30ml bottle

6) Notary attested copy of Non-conviction certificate for the manufacturing unit bearing license no. G/2332-A not submitted.

7) Product permit and market standing certificate submitted is for “Capsules” instead of tendered specification for D01053- Pregabalin Tab 75mg.

8) Notary attested copy of Performance statement in Anx IV not submitted for D15070- Moxifloxacin Eye Ointment 5%w/w, 5gm tube.

9) Notary attested copy of WHO-GMP certificate issued for the license no. KD-2149-A, PD-3280-A, Raj-1704-A and L/07/475/MB not submitted.

Bid No. 49 M/s. Aurolab, Madurai


Notary attested copy of Product permit is not submitted in “IP” specification for D15021- Brimonidine Eye Drops IP 0.20%, 5 ml and D15006- Tropicamide Eye Drops IP 1%w/v, 5ml.

2. D15036 HYDROXYPROPYL METHYL CELLULOSE OPHTHALMIC SOLUTION

2% 2 ml[PFS]

3. D15060 TROPICAMIDE + PHENYLEPHRINE OPHTHALMIC SOLUTION

0.8% + 5% 5 ml

4. D15006 TROPICAMIDE EYE DROPS IP 1%w/v 5ml

Bid No. 50 M/s. Bharat Serums & Vaccines Ltd, Thane

1. D21012 ANTI SNAKE VENOM (

FREEZE DRIED) POLYVALENT INJ

10 ml Vial 1) Notary attested copy of Valid

Renewal certificate for D21012- Anti Snake Venom (Freeze Dried) Polyvalent Inj 10 ml Vial and D21015- Equine Anti Rabies Immunoglobulin Inj 300 i.u./ml, 5 ml Vial in License no.

2. D16002/12 CARBOPROST TROMETHAMINE INJ IP 250 mcg/ml 1 ml Vial/Amp

3. D21015 EQUINE ANTI RABIES IMMUNOGLOBULIN INJ 300 IU/ml 5 ml Vial

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


4. D21011 HUMAN ANTI D IMMUNOGLOBULIN INJ IP

300 mcg Vial KD-4 not submitted.

2) Notary attested copy of Valid WHO-GMP certificate is not submitted.

3) Notary attested copy of Performance statement in Annnexure IV not submitted for any of the quoted items.

4) Tendered monograph specification not mentioned in the product permit and market standing certificate submitted for D21011- Human Anti D Immunoglobulin Inj IP 300 mcg Vial.

5) The purchase order issued by the Tender Inviting Authority for D13066- Streptokinase Inj IP 750000 IU in the financial year 2018-19 was cancelled due to non-supply.

5. D13066 STREPTOKINASE INJ IP 750000 IU Vial

6. D21010 TETANUS IMMUNOGLOBULIN INJ IP 250 IU Vial/Amp

Bid No. 51 M/s. Abbott India Ltd, Mumbai

1. D20037 URSODESOXYCHOLIC ACID TAB IP 300 mg 1 No 1) Brand name only mentioned in

the bid offer form (Anx II) submitted for all the quoted items.

2) Tendered Monograph specification not mentioned in the bid offer form (Anx II) submitted for D20015- Lactulose Solution USP 667 mg/ml, 100ml.

3) Previous import licenses issued three years prior to the date of notification of tender for the import of D04022- Isoflurane Liquid 100ml bottle not submitted.

2. D20015 LACTULOSE SOLUTION USP 667 mg/ml 100 ml

3. D04022 ISOFLURANE LIQUID 100 ml Bottle

Bid No. 52 M/s. Theon Pharmaceuticals Ltd, Haryana

1. D02004 AMOXYCILLIN CAP IP 250 mg 1 No Details of manufacturing units in Annexure VII submitted are not

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


2. D02005 AMOXYCILLIN CAP IP 500 mg 1 No attested by Notary public.



5. D02026 CEFOTAXIME SODIUM INJ IP

1gm Vial


7. D02036/ 12 AMOXICILLIN AND POTASSIUM CLAVULANATE TAB IP

500 mg+ 125 mg

1 No



10. D02056 CEFOPERAZONE + SALBACTUM INJ 1gm+ 0.5gm Vial





15. D05029 MONTELUKAST TAB IP 10 mg 1 No



18. D16017 MIFEPRISTONE TAB IP 200 mg 1 No

19. D20037 URSODEOXYCHOLIC ACID TAB IP 300 mg

1 No


Bid No. 53 M/s. Abbott Healthcare Pvt Limited, Mumbai

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


1. D13002 ISOSORBIDE DINITRATE TAB IP

10 mg 1 No 1) Ten items were offered by the

bidder in the Bid offer form (Anx II) in excel format, while only five items is mentioned in the Bid offer form (Anx II) in pdf format.

As per tender clause no. 6.15.3,” Bid offer form (Annexure-II) in PDF format submitted online alone will be considered for bid evaluation. If any discrepancy found with excel format, details submitted in the PDF format will prevail.”

2) Brand name only mentioned in the bid offer form (Anx II) and performance statement (Anx IV) submitted for all the quoted items.

3) Notary attested copy of WHO-GMP certificate submitted expired on 08.08.2018 and hence not valid.

2. D17001 DIAZEPAM TAB IP 5 mg 1 No


4. D17047 CHLORDIAZEPOXIDE TAB IP 25 mg 1 No


Bid No. 54 M/s. Chethana Formulations Pvt Ltd, Kerala


0.1% w/v 10ml BOTTLE

1) Tendered monograph specification not mentioned in the bid offer form (Anx II), Product permit and Market standing Certificate submitted for D15071- Oxymetazoline Hydrochloride Nasal Solution (Paediatric) IP 0.025% w/v 10ml.

2) Notary attested copy of original manufacturing license in Form 25 not submitted.

2. D15011 SALINE NASAL DROPS 0.65%w/v 15ml BOT

3. D 15071 OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTION (PAEDIATRIC) IP

0.025% w/v 10ml

Bid No. 55 M/s. Axa Parenterals Ltd, Roorkee

1. D03025 BUDESONIDE NEBULISING SOLUTION

0.5 mg/ml 2 ml Respules

1) The dosage form is mentioned as “Suspension” in the product permit and market standing certificate submitted for D03025- Budesonide

2. D15022 CARBOXY METHYL CELLULOSE EYE DROPS IP

0.50% 10 ml

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code



0.3% w/v 5 ml bottle Nebulising Solution 0.5 mg/ml, 2 ml Respules.

2) Notary attested copy of Market standing Certificate not submitted for D15046- Ofloxacin Ear/Eye Drops 0.30%, 10 ml.

3) Performnace Statement in Annexure IV submitted is not attested by Notary public.

4. D15032 GENTAMYCIN EYE DROPS IP

0.3% w/v 5 ml

5. D02076 LINEZOLID INJ 200 mg/100 ml

300 ml bottle


0.50% 5 ml


0.30% 10 ml

8. D01035 PARACETAMOL INFUSION IP

1gm/100ml 100 ml Bottle


0.5%w/v 5 ml/bottle

Bid No. 56 M/s. Shreya Life Sciences Pvt Ltd, Mumbai


elemental Iron/ml

5ml AMP 1) Drug code is wrongly

mentioned as “D22036” in the bid offer form (Annexure II) for D22016- Iron Sucrose Inj USP 20 mg elemental Iron/ml, 5ml amp.

2) Tendered monograph specification not mentioned in the bid offer form (Annexure II) for the following;

D21005- Insulin Injection Soluble IP 40 IU /ml, 10 ml Vial

D21006- Insulin Injection Isophane IP 40 IU /ml, 10 ml Vial

D21031- Insulin Injection Biphasic Isophane IP 30:70 (30% Soluble Insulin And 70% Isophane Insulin) 40 IU /ml, 10 ml Vial

3) “USP” not mentioned in bid offer form (Annexure II) submitted for D20015- Lactulose Solution USP 667 mg/ ml, 100 ml

4) The purchase orders issued by the Tender Inviting Authority for D21006- Insulin Injection


3. D21031

INSULIN INJECTION BIPHASIC ISOPHANE IP 30:70 (30% SOLUBLE INSULIN AND 70% ISOPHANE INSULIN)

40 IU/ML 10 ml vial

4. D21006 INSULIN INJECTION ISOPHANE IP

40 IU/ml 10 ml Vial

5. D21005 INSULIN INJECTION SOLUBLE IP

40 IU /ml 10 ml Vial

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


Isophane IP 40 IU /ml, 10 ml Vial and D21031- Insulin Injection Biphasic Isophane IP 30:70 (30% Soluble Insulin And 70% Isophane Insulin) 40 Iu /ml, 10 ml Vial for the financial year 2018-19 were cancelled due to non-supply.

Bid No. 57 M/s. Swiss Parenterals Ltd, Ahmedabad

1. D13062 ADENOSINE INJ IP 3mg/ml 2ml amp 1) Drug code and strength is

wrongly mentioned in the bid offer form (Anx II) for D29005- Noradrenaline Sterile Concentrate IP 0.2%, 2ml amp.

2) Drug code is wrongly mentioned as “D02049” in the bid offer form (Anx II) for D02052- Azithromycin Inj 500mg, 10ml vial.

3) Strength is different in the product permit submitted for D07011- Midazolam Inj IP 1mg/ml, 5ml vial.

4) Tendered monograph specification not mentioned in the product permit submitted for D13062 - Adenosine Inj IP 3mg/ml, 2ml amp

5) Tenderd monograph specification is different in the product permit submitted for the following;

D02034- Ceftriaxone Inj IP 1gm vial

D05001- Dexamethasone Inj IP 4mg/ml, 2ml vial

D04008- Neostigmine Methyl Sulphate Inj IP 0.5 mg/ml, 1ml amp

D02083- Piperacillin+


1mg/ml 1 ml Amp

3. D02091 AMIKACIN SULPHATE INJ IP 250mg/2ml 2ml Vial

4. D03003 AMINOPHYLLINE INJ IP 25mg/ml 10ml Amp


1.2gm Vial

6. D02052 AZITHROMYCIN INJ 500mg 10 ml Vial





11. D05001 DEXAMETHASONE INJ IP 4 mg/ml 2 ml Vial

12. D13016 DOPAMINE HCL INJ IP/USP 40 mg/ml 5 ml

13. D17012 HALOPERIDOL INJ IP 5mg/ml 1ml Amp


15. D05002 HYDROCORTISONE SODIUM SUCCINATE INJ IP 100 mg Vial

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


16. D04001 KETAMINE INJ IP 50 mg/ml 10 ml Vial Tazobactam Inj IP 2gm + 250mg Vial

D02039- Piperacillin 4gm + Tazobactam 500 Mg Inj IP 4.5gm Vial

D12015- Tranexamic Acid Inj IP 500mg/5ml, 5ml amp

6) Notary attested copy of Product permit not submitted for the following;

D02052- Azithromycin Inj 500mg, 10ml vial

D29005- Noradrenaline Sterile Concentrate IP 0.2%, 2ml amp

7) Strength not mentioned in the product permit submitted for D05009- Promethazine Inj IP 25mg/ml, 2ml amp


9) Valid market standing certificate not submitted for any of the offered items.

17. D13063 LABETALOL INJ IP 5mg/ml 4ml amp

18. D17034 LORAZEPAM INJ IP 2 mg/ml 2 ml Amp

19. D05028 METHYL PREDNISOLONE SODIUM SUCCINATE INJ USP

1gm Vial

20. D07011 MIDAZOLAM INJ IP 1 mg/ml 5 ml Vial

21. D04008 NEOSTIGMINE METHYL SULPHATE INJ IP 0.5 mg/ml 1 ml Amp

22. D29005 NORADRENALINE STERILE CONCENTRATE IP 0.20% 2 ml amp

23. D07008 PHENYTOIN SODIUM INJ IP/BP/USP 50mg/ml 2ml Amp


4.5gm Vial

25. D02083 PIPERACILLIN+ TAZOBACTAM INJ IP

2gm + 250mg Vial

26. D05009 PROMETHAZINE INJ IP 25 mg/ml 2ml Amp

27. D04012 SODIUM BICARBONATE INJ IP 7.5% w/v 10ml Amp

28. D12015 TRANEXAMIC ACID INJ IP 500mg/5ml 5ml amp

29. D02027 VANCOMYCIN IV INFUSION IP 500mg Vial

Bid No. 58 M/s. ANG Life Sciences India Pvt Ltd, HP


1.2 g Vial 1) Tendered monograph

specification not mentioned in the Bid offer form (Anx II) for the following;

D20018- Pantoprazole Inj BP 40 mg, 10ml vial.

D02083- Piperacillin+ Tazobactam Inj IP 2gm + 250mg, Vial

D05002- Hydrocortisone



100 mg Vial

4. D20018 PANTOPRAZOLE INJ BP 40 mg 10 ml VIAL


2gm + 250mg Vial

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


6. D04014 THIOPENTONE SODIUM INJ IP

0.5 gm Vial Sodium Succinate Inj IP 100 mg Vial

2) Market standing certificate submitted is for “USP” specification instead of “IP” for D02083- Piperacillin+ Tazobactam Inj IP 2gm + 250 MG.

3) Valid Market standing certificate not submitted for D02020- CEFUROXIME INJ IP 750 mg vial.


Bid No. 59 M/s. Vivek Pharmachem [India] Ltd, Jaipur

1. D08001 ALBENDAZOLE TAB IP 400 mg 1 No 1) Strength is different in the bid offer form (Anx II) submitted for D15044- Nepafenac Ophthalmic Suspension 0.1%w/v, 5ml

2) Tendered monograph specification not mentioned in the product permit submitted for D15021- Brimonidine Eye Drops IP 0.20%, 5ml

3) Monograph is different than that of tendered in the product permit submitted for the following;

D02055- Cefixime Tab IP 200 mg

D20018- Pantoprazole Inj BP 40mg, 10ml vial



D01028- Diclofenac Sodium Gel IP 1% w/w, 25gm tube


1.2 gm Vial



5. D02033 AMOXYCILLIN ORAL SUSPENSION IP 250 mg/5 ml 60 ml Bottle



8. D02008 AMPICILLIN INJ IP 500 mg Vial

9. D02093 AZITHROMYCIN ORAL SUSPENSION IP 200 mg/ 5ml 30ml bottle





…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


14. D02034 CEFTRIAXONE INJ IP 1gm Vial D21003- Metformin Tab IP 500mg


D02039- Piperacillin 4gm + Tazobactam 500 Mg INJ IP 4.5gm Vial


5) Tendered monograph specification not mentioned in the market standing certificate submitted for the following;

D15021- Brimonidine Eye Drops IP 0.20%, 5ml

D15027- Dorzolamide + Timolol Eye Drops IP 2% + 0.5%, 5 ml

D15041- Moxifloxacin Eye Drops IP 0.50%, 5ml

D22006- Ferrous Sulphate Tab IP 200mg

D12002- Folic Acid Tab IP 5mg

D21003- Metformin Tab IP 500mg

D20018- Pantoprazole Inj BP 40mg, 10ml vial

6) Monograph is different than that of tendered in the market standing certificate submitted for D14043- Povidone Iodine Ointment USP 5%w/w, 10gm tube

7) Strength not mentioned in the market standing certificate submitted for the following;

D02093- Azithromycin Oral Suspension IP 200 mg/ 5ml,


16. D02112 CEPHALEXIN ORAL SUSPENSION (DRY) IP

125 mg/5ml 60 ml Bottle


0.3%w/v 5ml Bottle




1% w/w 25gm Tube

21. D01005 DICLOFENAC SODIUM INJ IP

25 mg/ml 3 ml amp

22. D01004 DICLOFENAC SODIUM TAB IP (GASTRO-RESISTANT)

50 mg. 1 No

23. D15027 DORZOLAMIDE + TIMOLOL EYE DROPS IP

2% + 0.5% 5 ml

24. D02014/12 DOXYCYCLINE TAB USP 100 mg 1 No




100 mg Vial


elemental Iron/ml

5ml Amp

29. D04038 LIGNOCAINE HCL INJ IP (FOR IM USE) 2% w/v 10 ml Vial




33. D05028 METHYL PREDNISOLONE SODIUM SUCCINATE INJ USP

1gm Vial

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


34. D02024 METRONIDAZOLE TAB IP 400 mg 1 No 30ml bottle

D01009- Paracetamol Inj 150mg/2ml, 2ml amp

8) D22004/12- Vitamin Multi

Tab(Film Coated) was blacklisted by KMSCL upto 14.08.2021 vide Order no.KMSCL/QC/750/2017 dated 15.08.2018

9) The purchase order issued by the Tender Inviting Authority during the year 2018-19 for D02112- Cephalexin Oral Suspension (Dry) IP 125mg/5ml was cancelled due to non-supply.

35. D16026 MISOPROSTOL TAB IP 200mcg 1 No


0.50% 5 ml

37. D15044 NEPAFENAC OPHTHALMIC SUSPENSION

0.1%w/v 5ml

38. D02016 NORFLOXACIN TAB IP 400 mg 1 No


40. D20018 PANTOPRAZOLE INJ BP 40 mg 10 ml Vial

41. D01009 PARACETAMOL INJ 150 mg/2ml 2ml Amp.


4.5gm Vial


2gm + 250 mg Vial

44. D14043 POVIDONE IODINE OINTMENT USP 5%w/w 10gm Tube



47. D22004/12 VITAMIN MULTI TAB(FILM COATED)

Each Tablet Containing Vitamin A-

2500 iu Vitamin-D

200 iu Vitamin-B1 2 mg Vitamin-

B2 2 mg Vitamin B6

0.5 mg

CalciumPa ntothenate- 1 mg Niacinam ide- 25 mg

Vitamin -C 50 mg

Folic Acid-0.2 mg

1 No

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


48. D18011 WATER FOR INJECTION IP 10ml Amp

49. D14005 WHITFIELDS OINTMENT IP 15 gm Tube

Bid No. 60 M/s. Eurolife Healthcare Pvt Ltd, Mumbai


0.3%w/v 5ml Bottle

Tendered monograph specification not mentioned in the market standing certificate submitted for the following;

D15002- Ciprofloxacin Eye/Ear Drops IP 0.3%w/v, 5ml bottle


2. D18003 DEXTROSE INJ IP 5% 500ml Bot

3. D18007/ 12

ELECTROLYTE P(MULTI ELECTROLYTE IN D 5%) INJ

500ml Bottle


5. D18002 SODIUM CHLORIDE & DEXTROSE INJ IP 0.9%+5%w/v 500ml Bottle

6. D18001 SODIUM CHLORIDE INJ IP 0.9%w/v 500ml

Bot


Bid No. 61 M/s. Kwality Pharmaceuticals Ltd, Amritsar

1. D19006 ACETAZOLAMIDE TAB IP 250 MG 1 NO 1) Tendered monograph

specification not mentioned in the Bid offer form (Anx II) for the following;

D24108C- Hydroxy Urea Cap IP 500mg

D13017- Dobutamine Hcl Inj IP 50 mg/ml, 5ml amp

2) Drug code and specification wrongly mentioned in the Bid offer form (Anx II) for D14055- Salicylic Acid Ointment IP 6%, 30gm tube.

3) Pack size wrongly mentioned in the Bid offer form (Anx II) for D22032- Thiamine Inj IP 100 mg/ml, 2ml.

4) Strength wrongly mentioned in

2. D05005 ADRENALINE BITARTRATE INJ IP 1 MG/ML 1ML AMP

3. D01013 ALOPURINOL TAB IP 100 MG 1 NO

4. D02091 AMIKACIN SUPLHATE INJ IP 250 MG/2ML 2ml VIAL

5. D02033 AMOXYCILLIN ORAL SUSPENSION IP 250 MG/5ML

60ML BOTTLE

6. D01049 BACLOFEN TAB IP 10 MG 1NO

7. D20012 BISACODYL TAB IP 5 MG 1NO

8. D04030 BUPIVACAINE INJ IP 0.25% 20ML VIAL

9. D04031 BUPIVACAINE INJ IP 0.50% 20ML VIAL

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


10. D22025 CALCIUM CARBONATE+VITAMIN D3 SUSPENSION

200 MG+200IU

100 ML BOTTLE

the Bid offer form (Anx II), product permit and market standing certifiacte for D12015- Tranexamic Acid Inj IP 500mg/5ml, 5ml amp.

5) Notary attested copy of Prodcut permit not submitted for the following;

D02091- Amikacin Suplhate Inj IP 250 MG/2ML, 2ml vial

D22025- Calcium Carbonate+Vitamin D3 Suspension 200 MG+200IU, 100ml bottle

D02080- Nitrofurantoin Tab IP 100mg


D14031- Clobetasole Propionate Cream IP 0.05%, 15GM TUBE

D13017- Dobutamine Hcl Inj IP 50 mg/ml, 5ml amp

D04019- Glycopyrrolate Inj IP 0.2 MG/ML, 1ML AMP

D24108C- Hydroxy Urea Cap IP 500mg

D13063- Labetalol Inj IP 5 MG/ML, 4ml amp

D16007- Magnesium Sulphate Inj IP 500 mg/ml, 2ml amp

D07011- Midazolam Inj IP 1 MG/ML, 5ml vial

D13028- Nitroglycerin Inj IP 25 MG/5ML, amp

D12005- Phytomenadione (Vitamin K1) Inj IP 10 MG/ML,

11. D15022 CARBOXYMETHYL CELLULOSE EYE DROPS IP 0.50% 10ML

12. D05008 CHLOROPHENIRAMINE MALEATE INJ IP 10 MG/ML 1ML AMP

13. D14031 CLOBETASOLE PROPIONATE CREAM IP 0.05% 15GM TUBE

14. D08008 CLOTRIMAZOLE VAGINAL PESSARIES IP 200 MG 1NO

15. D02029 CLOXACILLIN INJ IP 500 MG IM/IV VIAL

16. D17014 CLOZAPINE TAB IP 25 MG 1NO

17. D17015 CLOZAPINE TAB IP 100 MG 1NO

18. D05021 DEFLAZACORT TAB 6 MG 1NO

19. D13017 DOBUTAMINE HCL INJ IP 50 mg/ml 5 ml Amp

20. D17013 FLUPHENAZINE DECANOATE INJ IP 25 MG 1ML AMP

21. D04019 GLYCOPYRROLATE INJ IP 0.2 MG/ML 1ML AMP

22. D16024 HYDROXY PROGESTRONE INJ IP 250 MG/ML 2ML AMP

23. D24108C HYDROXY UREA CAP IP 500 MG 1 NO

24. D04001 KETAMINE INJ IP 50 MG/ML 10ML VIAL

25. D01051 KETOROLAC TROMETHAMINE INJ IP 30 MG/ML 1ML AMP

26. D13063 LABETALOL INJ IP 5 MG/ML 4ML AMP

27. D13051 LABETALOL TAB IP 100 MG 1 NO

28. D16007 MAGNESIUM SULPHATE INJ IP 500 mg/ml 2ml amp

29. D13039 METHYL DOPA TAB IP 250 MG 1 NO

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


30. D07011 MIDAZOLAM INJ IP 1 MG/ML 5ML VIAL 1ml amp

D01046- Piroxicam Tab IP 20mg

D18014- Potassium Chloride Inj IP 15%W/V, 10ml amp

D22032- Thiamine Inj IP 100 mg/ml, 2ml

D12014- Tranexamic Acid Tab IP 500mg

D04020- Vecuronium Bromide Inj IP 4mg vial

D04021- Vecuronium Bromide Inj IP 10mg vial

D22024- Zinc Sulphate Dispersible Tab IP

7) Notary attested copy of Product permit, market standing certificate and performance statement not submitted for D13065- Nifedipine Prolonged-Release Tab IP 10mg.

8) Notary attested copy of Market standing certificate not submitted for D15022- Carboxymethyl Cellulose Eye Drops IP 0.50%, 10ml.

9) The firm was blacklisted by KMSCL upto 18.09.2020 vide Order no.KMSCL/ED/573/2016 dated 19.09.2017 for default supply.

31. D16026 MISOPROSTOL TAB IP 200mcg 1 NO

32. D13065 NIFEDIPINE PROLONGED RELEASE TAB IP

10 MG 1NO

33. D02080 NITROFURANTOIN TAB IP 100 MG 1NO

34. D13028 NITROGLYCERIN INJ IP 25 MG/5ML AMP

35. D01008 PENTAZOCINE LACTATE INJ IP

30 MG/ML 1ML AMP


50 MG/ML 2ML AMP

37. D12005 PHYTOMENADIONE (VITAMIN K1) INJ IP

10 MG/ML 1ML AMP

38. D01046 PIROXICAM TAB IP 20 MG 1NO

39. D18014 POTASSIUM CHLORIDE INJ IP

15%W/V 10ML AMP

40. D17041 PROCHLORPERAZINE INJ IP 12.5 MG/ML 1ML AMP

41. D05009 PROMETHAZINE INJ IP 25 MG/ML 2ML AMP

42. D04010 PROPOFOL INJ IP 1%W/V 20ML AMP

43. D04011 PROPOFOL INJ IP 1%W/V 50ML VIAL

44. D17056 QUEITAPINE TAB IP 100 MG 1NO

45. D14055 SALICYLIC ACID OINTMENT IP

6% 30gm tube

46. D04012 SODIUM BICARBONATE INJ IP

7.5%W/V 10ML AMP

47. D07023 SODIUM VALPROATE ORAL SOLUTION IP

200mg/5ml 100 ml Bottle

48. D22032 THIAMINE INJ IP 100 MG/ML 2ml

49. D12015 TRANEXAMIC ACID INJ IP 500 MG/5ML 5ML AMP

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


50. D12014 TRANEXAMIC ACID TAB IP 500 MG 1NO


4 MG VIAL


10 MG VIAL

53. D12001/12 VITAMIN B12/CYANOCOBALAMIN INJ IP

100MCG/ML 2ML AMP

54. D12021 WARFARIN SODIUM TAB IP 5 MG 1NO

55. D12020 WARFARIN SODIUM TAB IP 1 MG 1NO

56. D15009 XYLOMETAZOLINE NASAL DROPS IP 0.1% W/V

10ML BOTTLE


20 MG ELEMNTAL

ZINC 1NO

Bid No. 62 M/s. Esgee Pharmaceuticals, Thiruvananthapuram

1. D14027 TURPENTINE LINIMENT I.P. 100 ml bottle

1) Annual turn over statement for the year 2017-18 is not submitted.

2) The average annual turn over of the bidder (State MSME) is less than Rs.50 Lakhs and hence the eligibility criteria for participating in the tender as per Clause 5.2.2.2 is not complied with.

3) Notary attested copy of Audited Balance sheet and Profit & Loss statement for the year 2017-18 is not submitted.

2. D14024 LIQUID PARAFFIN I.P. 100 ml bottle

Bid No. 63 M/s. Vins Bio Products Ltd, Hyderabad

1. D21012 ANTI SNAKE VENOM (FREEZE DRIED) POLYVALENT INJ

10ml Vial 1) Product permit for the offered

items issued three years prior to the date of notification of tender not submitted.

2. D21015 EQUINE ANTI RABIES IMMUNOGLOBULIN INJ 300 IU/ml 5 ml Vial

Bid No. 64 M/s. Daffodils Pharmaceuticals Ltd, Meeret

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


1. D01019 ACECLOFENAC TAB IP 100 mg 1 NO 1) Tendered monograph

specification not mentioned in the bid offer form (Anx II) submitted for the following;

D04007- Atropine Sulphate Inj IP 0.6 mg/ml, 1ml amp

D14030/12- Calamine Lotion IP 50ml bottle


D07008- Phenytoin Sodium Inj IP/BP/USP 50 mg/ml, 2ml amp.

D02039- Piperacillin 4gm + Tazobactum 500 mg INJ IP 4.5gm Vial

D14043- Povidone Iodine Ointment USP 5%w/w, 10 gm Tube

2) “For IM Use” not specified in the bid offer form (Anx II) submitted for D04038- Lignocaine Hcl Inj IP (FOR IM USE) 2%w/v, 10ml vial.

3) Drug name wrongly mentioned in the bid offer form (Anx II) for D03001- Theophylline And Etophylline Inj 50.6 mg + 169.4 mg, 2 ml Amp.

4) Product permit and market standing certificate submitted is in “USP” instead of tendered specification of “IP” for the following;

D20009- Dicyclomine Hcl Inj IP 10 mg /ml, 2ml amp.

D14035- Mupirocin Ointment IP 2%w/w, 5gm tube

5) Tendered monograph specification not mentioned in the product permit submitted


1 MG/ML 1 ML AMP

3. D02004 AMOXYCILLIN CAP IP 250 mg 1 NO

4. D02005 AMOXYCILLIN CAP IP 500 mg 1 NO

5. D02007 AMPCILLIN CAP. IP 250 mg 1 NO

6. D02041 AMPICILLIN CAP. IP 500 mg 1 NO

7. D02008 AMPICILLIN INJ IP 500 mg Vial

8. D04007 ATROPINE SULPHATE INJ IP 0.6 MG/ML 1 ML AMP

9. D05004 BETAMETHASONE SODIUM INJ. IP

4 MG/ML 1 ML AMP

10. D14030/12 CALAMINE LOTION IP 50 ML BOTTLE

11. D02026 CEFOTAXIME SODIUM INJ IP 1 GM VIAL

12. D02034 CEFTRIAXONE INJ IP 1 GM VIAL

13. D02020 CEFUROXIME INJ IP 750 mg VIAL

14. D05018 CETIRIZINE SYRUP IP 5 mg /5 ML 30 ML BOTTLE


0.05% 15 GM TUBE


1%W/W 25 gm Tube

17. D01005 DICLOFENAC SODIUM INJ IP 25 MG/ML 3 ML AMP

18. D20009 DICYCLOMINE HCL INJ IP 10 mg /ML 2 ML AMP

19. D20007/12 DOMPERIDONE TAB IP(FILM COATED)

10 mg 1 No

20. D13016 DOPAMINE HCL INJ IP/USP 40 MG/ML 5 ML

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


21. D14032 FUSIDIC ACID CREAM IP 2% 10 gm tube for the following;

D02016- Norfloxacin Tab IP 400mg

D02039- Piperacillin 4gm + Tazobactum 500 mg INJ IP 4.5gm Vial

6) Notary attested copy of Product permit and market standing certificate not submitted for D20018- Pantoprazole Inj BP 40 mg, 10ml Vial.

7) Notary attested copy of Product permit not submitted for D02008- Ampicillin InJ IP 500 mg.

8) Product permit submitted is for Diclofenac Diethyl Ammonium Gel instead of tendered specification for D01028-Diclofenac sodium gel IP.

9) Bid offer form (Anx II), Product permit and market standing certificate submitted is for “Uncoated Tablets” instead of the tendered specification for D20007/12- Domperidone Tab IP(Film Coated) 10mg.

10) The dosage form mentioned in the product permit submitted is “Cream” instead of “Ointment” for D14031- Clobetasole Propionate Cream IP 0.05%, 15gm tube.



D01028- Diclofenac Sodium Gel IP 1%w/w, 25gm Tube

12) Market standing certificate submitted is in “USP” instead of

22. D05002 HYDROCORTISONE SODIUM SUCCINATE INJ. IP

100 mg VIAL

23. D04038 LIGNOCAINE HCL INJ IP (FOR IM USE)

2%W/V 10 ML VIAL

24. D02024 METRONIDAZOLE TAB IP 400 mg 1 No

25. D14035 MUPIROCIN OINTMENT IP 2%W/W 5 gm Tube


27. D20018 PANTOPRAZOLE INJ BP 40 mg 10 ml VIAL


50 MG/ML 2 ML AMP

29. D02039 PIPERACILLIN 4GM + TAZOBACTUM 500 mg INJ IP

4.5 GM VIAL


5%W/W 10 gm Tube

31. D20001 RANITIDINE HCL INJ IP 50 mg /2ML 2 ML AMP

32. D03024 SALBUTAMOL SYRUP IP 2 MG/5 ML 60 ml BOTTLE


50.6 mg + 169.4 mg

2 ML AMP

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


tendered specification of “IP” for D02039- Piperacillin 4gm + Tazobactum 500 mg INJ IP 4.5gm Vial.

13) Notary attested copy of Performance statement in Anx IV not submitted for D05018- Cetirizine Syrup IP 5 mg /5 ML, 30ml bottle.

14) Performance statement in Annexure IV, Details of manufacturing units in Annexure VII and Details of technical persons employed submitted are not attested by Notary public.

15) The bidder has furnished 2 Bank guarentees as offline EMD. The validity of both the BGs submitted as balance EMD (up to 07.07.2019) is less than that required (25.08.2019) as per tender condition.

16) The purchase orders issued by the Tender Inviting Authority during the year 2018-19 for D05005- Adrenaline Bitartrate Inj IP 1 MG/ML & D14030/12- Calamine Lotion IP 50 ml in the financial year 2018-19 were

cancelled due to non-supply.

Bid No. 65 M/s. Gennova Biopharmaceuticals Limited, Pune

1. D12022 ERYTHROPOETIN RECOMBINANT INJ

4000 IU Vial/PFS

Notary attested copy of Audited balance sheet and Profit and loss statement for the year 2016-17 not submitted.

Bid No. 66 M/s. Synokem Pharmaceuticals Limited, New Delhi

1. D08001 ALBENDAZOLE TAB IP 400 mg 1 No 1) Tendered monograph

specification not mentioned in the product permit and market standing submitted for D22026- 2. D13013 ATORVASTATIN TAB IP 10 mg 1 No

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


3. D02063 CIPROFLOXACIN +TINIDAZOLE TAB

500 mg + 600 mg

1 No Vitamin D3 Drops BP 400IU/ml, 15ml.

2) Strength not mentioned in the Market standing certificate submitted for D07018- Levetiracetam Tab IP 500mg.

3) The firm was blacklisted by Haryana Medical Services Corporation Limited (HMSCL) from upto 06.12.2020 Endst no 3/4- A170 (T&IT) HMSCL/2016/0489-98 dated 07.12.2017.



mg, Guiphenesin

- 50 mg , Terbutaline Sulphate- 1.25 mg ,

Menthol- 2.5 mg,


q.s

50 ml Bottle







11. D16026 MISOPROSTOL TAB IP 200mcg 1 No

12. D13064 NEBIVOLOL TAB IP 5 mg 1 No

13. D16020 NORETHISTERONE TAB IP 5 mg 1 No


15. D07019 OXCARBAZEPINE TAB IP 150 mg 1 No

16. D20036 SUCRALFATE SUSPENSION 1g/5ml 100 ml bottle

17. D22033 THIAMINE TAB IP 100 mg 1 NO

18. D20037 URSODEOXYCHOLIC ACID TAB IP 300 mg 1 No

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code



Bid No. 67 M/s. Unijules Life Sciences Ltd, Nagpur

1. D23001 IOHEXOL INJ USP 350 mg/ml 50ml

Submitted the required documents. 2. D23007 IOHEXOL INJ USP 350 mg/ml 100 ML BOTTLE

3. D14041 MICONAZOLE CREAM IP 2% w/w 10gm Tube


5. D07023 SODIUM VALPROATE ORAL SOLUTION IP


Bid No. 68 M/s. Labinduss Limited, Palakkad

1. D05018 CETIRIZINE SYRUP IP 5 mg/5ml 30 ml Bott 1) Pack size is not mentioned in

the bid offer form (Anx II) submitted for D03024- Salbutamol Syrup IP,2mg/5ml, 60 ml bottle.

2) Pack size is mentioned as “60ml” instead of tendered specification of “30ml” in the product permit for D05018- Cetirizine Syrup IP 5mg/5ml, 30ml bottle.

3) Pack size is mentioned as “60ml” instead of tendered specification of “50ml” in the product permit for D14030/12- Calamine Lotion IP 50ml bottle.

4) Pack size of “100ml” is not approved in the product permit submitted for D14027- Turpentine Liniment IP 100 ml bottle.

5) Tendered monograph specification not mentioned in the product permit submitted for D14043- Povidone Iodine Ointment USP 5%w/w 10gm Tube.



mg,Guiphenesin-50 mg , Terbutaline

Sulphate-1.25 mg ,Menthol-

2.5 mg, Flavoured

syrupy base q.s

50 ml Bottle



4. D14030/12 CALAMINE LOTION I.P 50 ml bottle

5. D14027 TURPENTINE LINIMENT IP 100 ml bottle

6. D03024 SALBUTAMOL SYRUP IP 2 mg/5ml 60 ml bottle


5%w/w 10gm Tube

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


6) Market standing certificate submitted is in “IP” instead of “USP” for D14043- Povidone Iodine Ointment USP 5%w/w 10gm Tube.

7) Notary attested copy of Performance statement in Annexure IV not submitted of D03034- Cough Syrup 50ml bottle.

Bid No. 69 M/s. Lupin Limited, New Delhi

1. D07018 LEVETIRACETAM TAB IP 500 mg 1 No 1) Drug code wrongly mentioned

in the bid offer form (Anx II) as “D03006” for D03059- Salbutamol Nebuliser Solution BP 5 mg/ml, 15ml.

2) Notary attested copy of original Manufacturing license/Loan license in Form 25& 28/25A&28A not submitted.

3) Tendered monograph specification not mentioned in the product permit and market standing certificate submitted for D03059- Salbutamol Nebuliser Solution BP 5mg/ml, 15 ml.

4) “USP” is mentioned instead of tendered specification of “IP” in the product permit submitted for D07018- Levetiracetam Tab IP 500 mg.

5) Market standing certificate not submitted for D07018- Levetiracetam Tab IP 500 mg.


3. D03013 IPRATROPIUM NEBULISING SOLUTION

250mcg/ml 15 ml

Bid No. 70 M/s. Emcure Pharmaceuticals Ltd, Pune


40 mg / 0.4 ml

Vial/ PFS Submitted the required documents.

Bid No. 71 M/s. Murugan Pharma, Kollam

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


1. D03009

EXPECTORANT MIXTURE CONCENTRATE (EACH 5ML CONTAINS:-CAMPHORATED OPIUM TINCTURE IP 66-1.62 ML,TINCTURE IPECACUANHA IP 66 - 0.875ML, TINCTURE URGENIA IP 66-0.75 ML,AROMATIC SPIRIT OF AMMONIA IP 66-0.875 ML,CHLOROFORM IP-0.025 ML,WATER-QS. ALCOCHOL CONTENT 40-45% V/V)

500 ml bottle

The firm has neither furnished Earnest Money Deposit (EMD) as stipulated in the tender document nor documentary proof that the firm is registered with the Industries Department of the State of Kerala not submitted.

2. D20013

MIXTURE CARMINATIVE CONCENTRATE(EACH 10ML,CONTAINS:WEAK GINGER TINCTURE BP/IP-0.625ML,AROMATIC SPIRIT OF AMMONIA IP-0.625ML,PEPPERMINT SPIRIT BP-0.25ML,CHLOROFORM IP-0.019ML,SODIUM BICARBONATE IP-0.275 GM, COMPOUND CARDAMOM TINCTURE IP-3.0 ML, AQUA Q.S-10 ML, ALCOHOL CONTENT-20-26% V/V)

500 ml bottle

3. D14027 TURPENTINE LINIMENT IP 100 ml bottle

Bid No. 72 M/s. Akums Drugs and Pharmaceuticals Ltd, Haridwar

1. D01019 ACECLOFENAC TAB IP 100 mg 1 No 1) Tendered monograph

specification not mentioned in the product permit submitted for the following;



2) Renewal certificate not submitted for license no. 123/UA/2007 & 129/UA/SC-P-2007.

3) Tendered monograph specification is different in the

2. D02091 AMIKACIN SULPHATE INJ IP 250 mg/2ml 2ml Vial

3. D02049 AMOXYCILLIN AND

POTASSIUM CLAVULANATE INJ IP

1.2gm Vial


5. D02093 AZITHROMYCIN ORAL SUSPENSION IP

200 mg/5 ml

30ml bottle



…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


8. D14030/12

CALAMINE LOTION IP 50 ml bottle market standing certificate submitted for the following;


D22026- Vitamin D3 DropS BP 400IU/ml, 15ml


D22059- Calcium And Vitamin D3 Tab IP-Equivalent to elemental Calcium 500 mg and Vitamin D3 250 IU.

4) Market Standing Certificate not submitted for D20033- Pantoprazole (Gastro Resistant) Tab IP 40 mg.


Equivalent to elemental

Calcium 500 mg and Vitamin D3

250 IU

1 No

10. D15022 CARBOXY

METHYLCELLULOSE EYE DROPS IP

0.50% 10 ml

11. D02056 CEFOPERAZONE + SULBACTAM INJ

1gm+0.5gm Vial



14. D02012 CIPROFLOXACIN INJ IP 2 mg/ml 100ml Bottle




mg, Guiphenesi

n - 50 mg ,

Terbutaline Sulphate- 1.25 mg , Menthol- 2.5 mg,


q.s

50 ml Bottle

17. D20007/12

DOMPERIDONE TAB IP (FILM COATED)

10 mg 1 No

18. D13032/12

ENALAPRIL MALEATE TAB IP(FILM COATED)

5 mg 1 No




…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code




24. D21032/ 12

GLIMEPIRIDE TAB IP 2 mg 1 No


26. D15035 HYDROXY PROPYL

METHYL CELLULOSE EYE DROPS

0.30% 10 ml


elemental Iron/ml

5ml Amp






40 mg/0.4 ml Vial/PFS



35. D05029 MONTELUKAST TAB IP 10 mg 1 No




39. D20004/12

OMEPRAZOLE (GASTRO RESISTANT) CAP IP 20 mg 1 No


41. D15071

OXYMETAZOLIN E HYDROCHLORIDE NASAL SOLUTION (PAEDIATRIC )

IP

0.025% w/v 10 ML

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code



40 mg 1 No

43. D01035 PARACETAMOL INFUSION IP

1gm/100ml 100 ml bottle



46. D02039 PIPERACILLIN 4GM +

TAZOBACTAM 500 mg INJ IP

4.5gm Vial



49. D20021 RABEPRAZOLE GASTRO

RESISTANT TAB IP 20 mg 1 No



52. D01041 SERRATIOPEPTIDASE TAB

IP 10 mg 1 No


GASTRO RESISTANT TAB IP

200 mg 1 No


GASTRO RESISTANT TAB IP

500 mg 1 No



0.3% v/v 5 ml bottle


58. D20037 URSODEOXYCHOLIC ACID TAB IP

300 mg 1 No




0.1% w/v 10 ml Bottle

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


Bid No. 73 M/s. Modern Laboratories, Indore

1. D01019 ACECLOFENAC TAB IP 100 mg 1 No 1) Notary attested copy of Original drug license in Form 25 & 28 not submitted.

2) Tendered monograph

specification not specified in the Product permit and Market standing certificate submitted for D22059- Calcium and Vitamin D3 Tab IP- Equivalent to elemental Calcium 500 mg and Vitamin D3 250 IU.

3) Valid Market Standing Certificate not submitted for D02055- Cefixime Tab IP 200mg.





Equivalent to elemental

Calcium 500 mg and

Vitamin D3 250 IU

1 No




500 mg + 600 mg 1 No





13. D02024 METRONIDAZOLE TAB IP 400 mg 1 No





20 mg elemental

Zinc 1 No

Bid No. 74 M/S. PULSE PHARMACEUTICALS PVT. LTD, Hyderabad

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


1. D17029 ESCITALOPRAM TAB IP 10 mg 1 No 1. Tendered monograph

specification not specified in the bid offer form (Anx II) submitted for the following;



2. Tendered Monograph specification not specified in the product permit and market standing certificate submitted, for the following;

D17020- Olanzapine Tab IP 5 mg


3. Product permit and market standing certificate submitted is for “Capsules” instead of Tablets for the following;

D01048- Tramadol Prolonged Release Tab IP 50 Mg

D01053- Pregabalin Tab 75 mg.

4. Market standing certificate submitted is for “USP” for D07018- Levetiracetam Tab IP 500 mg.

5. Market standing certificate is not submitted for D17059- Zolpidem Tab IP 10 mg.





6. D01053 PREGABALIN TAB 75 mg 1 No

7. D01048 TRAMADOL PROLONGED RELEASE TAB IP

50 MG 1 No

8. D17059 ZOLPIDEM TAB IP 10 mg 1 No

Bid No. 75 M/s. Ravian Life Sciences Pvt. Ltd, Haridwar

1. D13036 ACETYL SALICYLIC ACID

TAB IP(GASTRO RESISTANT)

150 mg 1 No 1. Tendered monograph

specification not mentioned in the product permit submitted for the following;

D21028- Glimepiride Tab IP 1 mg 1No

2. D13024 ACETYLSALICYLIC ACID

TAB IP(GASTRO RESISTANT)

75 mg 1 No

3. D13031/12 AMLODIPINE TAB IP(FILM

COATED) 5 mg 1 No

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


4. D13013 ATORVASTATIN TAB IP 10 mg 1 No D21032/12- Glimepiride Tab IP 2 mg 1No

2. D20041- Ondansetron Oral Solution IP 2 mg/5ml, 30ml bottle is licensed to manufacture for M/s. Lincoln Pharmaceuticals Ltd.

3. D07019- Oxcarbazepine Tab IP 150 mg is licensed to manufacture for M/s.Seagem Remedies.

4. Market standing certificate not submitted for the following;

D13013- Atorvastatin Tab IP 10 mg

D07019- Oxcarbazepine Tab IP 150 mg

D07004- Phenytoin Sodium Tab IP 100 mg 1 No

D21038- Voglibose Tab IP 0.2 mg

5. The strength of D21028-Glimepiride Tab IP 1mg, mentioned in the market standing certificate is 2mg.

6. Product permit submitted is for Voglibose Mouth Dissolving Tablets instead of D21038- Voglibose Tab IP 0.2 mg.

7. Market standing certificate submitted is issued for the purpose of participating in the tenders invited by TNMSCL and Odisha Medical Corporation Ltd.

8. Valid market standing certificate not submitted for the following;

D02017- Ofloxacin Tab IP 200 mg

D17016- Olanzapine Tab IP 10












16. D20004/12 OMEPRAZOLE (GASTRO RESISTANT) CAP IP

20 mg 1 No




19. D07019 OXCARBAZEPINE TAB IP 150 mg 1 No

20. D01003 PARACETAMOL

PAEDIATRIC SYRUP/SUSPENSION IP

125 mg/5ml 60ml Bottle



23. D13029/12 PROPRANOLOLTAB IP 20 mg 1 No

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


24. D13059 RAMIPRIL TAB IP 5 mg 1 No mg

D01003-Paracetamol Paediatric Syrup/Suspension IP 125 mg/5ml

D13059- Ramipril Tab IP 5 mg

D02031- Azithromycin Tab IP 500 mg


D13031/12- Amlodipine Tab IP(Film Coated) 5mg.




Bid No. 76 M/s. Micron Pharmaceuticals, Vapi

1. D19006. ACETAZOLAMIDE TAB IP 250 mg 1 No. 1) Tendered monograph

specification is not mentioned in the bid offer form (Anx II) and product permit submitted for D08030- Ketoconazole Cream BP 2%, 5gm tube.

2) Bid offer form (Anx II), Product permit and market standing certificate submitted is for “BP” specification instead of tendered specification of “USP” for the following;


D17017- Risperidone Tablets USP 2mg

3) Market standing certificate submitted is for “USP” specification instead of tendered specification of “IP” for D02086- Metronidazole Gel IP 1%, 25gm tube and the certificate is not valid.

4) Notary attested copy of Market standing certificate is not submitted for the following;

D17040- Prochlorperazine Tab

2. D17005 AMITRIPTYLINE TAB IP 25 mg 1 No.

3. D02031 AZITHROMYCIN TAB IP 500 mg 1 No.

4. D14026/12 BENZYL BENZOATE APPLICATION IP 25% w/w 100 ML

BOTTLE

5. D07005 CARBAMAZEPINE TAB IP 200 mg 1 No.

6. D08008 CLOTRIMAZOLE VAGINAL PESSARIES IP 200 mg 1 No.

7. D17001 DIAZEPAM TAB IP 5 mg 1 No.

8. D02014/12 DOXYCYCLINE TAB U.S.P. 100 mg 1 No.

9. D08014 FLUCONAZOLE TAB IP 150 mg 1 No.

10. D19001 FRUSEMIDE TAB IP 40 mg 1 No.

11. D14032 FUSIDIC ACID CREAM IP 2% 10 gm tube

12. D21028 GLIMEPRIDE TAB IP 1 MG 1 No.

13. D17010 HALOPERIDOL TAB IP 5 mg. 1 No.

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


14. D08030 KETOCONAZOLE CREAM BP 2% 5gm tube IP 5mg

D03002- Theophylline & Etofylline Tablets 23mg +77mg


5) Market standing certificate submitted is for “Capsule” instead of tendered specification of “Tablet” for D02014/12- Doxycycline Tab USP 100mg.

6) Valid Market Standing Certificate not submitted for the following;

D17001- Diazepam Tab IP 5mg

D02086- Metronidazole Gel IP 1% 25gm tube

7) The purchase order issued by the Tender Inviting Authority during the year 2018-19 for D14026/12- Benzyl Benzoate Application IP 25% w/w was cancelled due to non-supply.

15. D02078 LINEZOLID TAB IP 600 mg 1 No.


300 MG 1 No.

17. D17033 LORAZEPAM TAB IP 2 mg 1 no.

18. D02086 METRONIDAZOLE GEL IP 1% 25 gm Tube

19. D05029 MONTELUKAST TAB IP 10 MG 1 No.

20. D07001 PHENOBARBITONE TAB IP 30 mg 1 No.

21. D07002 PHENOBARBITONE TAB IP 60 MG 1 No.

22. D05034 PREDNISOLONE TAB IP 5 MG 1 No.

23. D05011 PREDNISOLONE TAB IP 10 MG 1 No.

24. D17040 PROCHLORPERAZINE TAB IP

5 MG 1 No.

25. D17037 RISPERIDONE TAB USP 1 MG 1 No.

26. D17017 RISPERIDONE TAB USP 2 MG 1 No.

27. D19003 SPIRONOLACTONE TAB IP 25 MG 1 No.

28. D03002 THEOPHYLLINE & ETOFYLLINE TABLETS

23 MG +77 MG

1 No.

29. D11001 TRIHEXYPHENIDYL TAB IP 2 MG 1 No.

30. D22020 VITAMIN C TAB IP 500 MG 1 No.

Bid No. 77 M/s. Variety Pharmaceuticals Private Limited, Shoranur

1. D01003 PARACETAMOL PAEDIATRIC SYRUP/ SUSPENSION IP

125 mg /5 ml 60 ml

Product permit submitted is for 60 ml pack size instead of tendered pack size of 50ml for D03034- Cough Syrup, 50 ml


…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code



Each 5 ML contain

Ambroxol HCl 15 mg+

Guaiphenesin 50 mg+ Terbutaline Sulphate

1.25 mg+ Menthol 2.5

mg flavoured

syrapy base q.s

50 ml BOTTLE

Bottle.

Bid No. 78 M/s. The Pharmaceuticals and Chemicals Travancore Pvt. Ltd, Trivandrum

1. D02004 Amoxycillin Cap IP 250 mg 1 No 1. Product permit submitted is for

60ml instead of tendered specification of 30ml for D05018- Cetirizine Syrup IP 5mg/ 5ml, 30 ml Bottle.

2. Notary attested copy of Performance statement (Annex-IV) for D02007- Ampicillin Cap IP 250 mg not submitted.

3. Details of 5 batches not mentioned in the performance statement submitted for the following;

D02041- Ampicillin Cap IP 500 mg 1 No

D14024- Liquid Paraffin IP 100ml, Bottle

4. The purchase orders issued by the Tender Inviting Authority for D01002- Paracetamol Tab IP 500 mg & D02005- Amoxycillin Cap IP 500 mg in the financial year 2018-19 were cancelled due to non-supply.

5. GMP certificate issued by the Licensing Authority not submitted.

6. Two batches (Batch nos PCT1713 & PCT1701) of D01003-Paracetamol Paediatric

2. D02005 Amoxycillin Cap IP 500 mg 1 No

3. D02007 Ampicillin Cap IP 250 mg 1 No

4. D02041 Ampicillin Cap IP 500 mg 1 No

5. D14030/ 12 Calamine Lotion IP 50 ml bottle

6. D05018 Cetirizine Syrup IP 5 mg/ 5ml 30 ml Bottle

7. D14024 Liquid Paraffin IP 100 ml Bottle

8. D01003 PARACETAMOL

PAEDIATRIC SYRUP/SUSPENSION IP


9. D01002 Paracetamol Tab IP 500 mg 1 No

10. D14027 Turpentine Liniment IP 100ml Bottle

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


Syrup/Suspension IP 125mg/5ml supplied by the firm during the year 2017-18 were declared as Not of Standard Quality.

As per Clause 5.2.8.7 “Tender should not be submitted for a product, if any two batches of that product manufactured and supplied by the company to KMSCL in the tender 2016-17, 2017-18 and 2018-19 had failed in quality.”

Bid No. 79 M/s. Sangrose Laboratories Private Limited, Mavelikkara

1. D13013 Atorvastatin Tab IP 10 mg 1 No. 1) Tendered monograph

specification not specified in the product permit submitted for the following;

D13013- Atorvastatin Tab IP 10mg

D08039- Clotrimazole Cream IP 1% w/w, 10gm

D14035- Mupirocin Ointment IP 2%w/w 5gm

2) Tendered monograph specification not specified in the product permit and market standing certificate submitted for the following;


D14055- Salicylic Acid Ointment IP 6%, 30gm tube

3) The dosage form mentioned in the product permit submitted is “Cream” instead of “Ointment” for D14035- Mupirocin Ointment IP 2%w/w 5gm.

4) Details of 5 batches not mentioned in the Performance Statement submitted for D13007/12- Verapamil Tab IP

2. D14031 Clobetasol Propionate Cream IP

0.05% 15gm Tube

3. D08039 Clotrimazole Cream IP 1% w/w 10gm tube

4. D08030 Ketoconazole Cream BP 2% 5gm Tube

5. D14035 Mupirocin Ointment IP 2%w/w 5gm

6. D14055 Salicylic Acid Ointment IP 6% 30gm tube

7. D13007/12 Verapamil Tab IP 40 mg 1 No.

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


40 mg.

Bid No. 80 M/s. Megasys Biotek Pvt. Ltd, Thrissur

1. D01019 ACECLOFENAC TAB IP 100 MG 1 NO 1. Tendered monograph

specification not mentioned in the bid offer form (Anx II) submitted for D15071-Oxymetazoline Hydrochloride Nasal Solution (Paediatric) IP 0.025%W/V, 10ml.

2. Details of 5 batches not mentioned in the performance statement submitted for the following;

D08014- Fluconazole Tab IP 150 MG

D15041- Moxifloxacin Eye Drops IP 0.50%, 5ML

2. D13013 ATORVASTATIN TAB IP 10 MG 1 NO

3. D05017 BETAHISTINE TAB IP 8 MG 1 NO

4. D13023 CLOPIDOGREL TAB IP 75 MG 1NO

5. D05021 DEFLAZACORT TAB 6 MG 1 NO

6. D08014 FLUCONAZOLE TAB IP 150 MG I NO

7. D02075 LEVOFLOXACIN TAB IP 500 MG 1 NO


0.50% 5ML

9. D15071 OXYMETAZOLINE

HYDROCHLORIDE NASAL SOLUTION(PAEDIATRIC) IP

0.025%W/V 10ML

10. D20033 PANTOPRAZOLE (GASTRO

RESISTANT) TAB IP 40 MG 1 NO

11. D20021 RABEPRAZOLE (GASTRO

RESISTANT) TAB IP 20 MG 1 NO

12. D01041 SERRATIOPEPTIDASE TAB

IP 10 MG 1 NO

13. D20036 SUCRALFATE SUSPENSION 1G/5ML 100ML

BOTTLE

14. D13061 TELMISARTAN

TAB IP 40 MG 1 NO

15. D15066 TOBRAMYCIN EYE/EAR

DROPS 0.3%V/V 5ML BOTTLE

Bid No. 81 M/s. Rusan Pharma Ltd, Mumbai

1. D04017 BUPIVACAINE IN DEXTROSE

INJ USP 0.50% 4 ml Amp

Notary attested copy of Performance statement in Annexure IV not submitted for the following; 2. D01023 FENTANYL CITRATE INJ IP 50mcg/ml

2 ml Amp

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code



0.20% 2ml amp D04017- Bupivacaine In Dextrose Inj USP 0.50%,4 ml Amp

D29005- Noradrenaline Sterile Concentrate IP 0.20%,2ml amp


Bid No. 82 M/s. Piramal Enterprises Limited, Mumbai

1. D04022 ISOFLURANE LIQUID 100ML BOTTLE Submitted the required documents.

Bid No. 83 M/s. Venus Remedies Limited, HP


Submitted the required documents.


elemental Iron/ml

5ml Amp

3. D12019 LOW MOLECULAR WEIGHT HEPARIN INJ IP 40 mg/0.4 ml Vial/PFS


Bid No. 84 M/s. Teecee Pharma, Trivandrum

1. D14024 LIQUID PARAFFIN IP 100ml Bot Submitted the required documents. 2. D01002 PARACETAMOL TAB IP 500 mg 1 No

3. D14027 TURPENTINE LINIMENT IP 100ml Bot

4. D14040 WHITE SOFT PARAFFIN IP 50gm BOTTLE

Bid No. 85 M/s. Celebrity Biopharma Limited, HP

1. D01019 ACECLOFENAC TAB IP 100 mg 1 No. 1) Drug code is wrongly

mentioned in bid offer form (Anx II) for D22059- Calcium And Vitamin D3 Tab IP Equivalent to elemental Calcium 500mg and Vitamin D3 250IU.

2) “Cap” is mentioned in the bid offer form (Anx II), product

2. D02093 AZITHROMYCIN ORAL SUSPENSION IP 200 mg/5 ml 30ml

bottle

3. D22025 CALCIUM CARBONATE + VITAMIN D3 SUSPENSION

200 mg + 200IU

100ml bottle



1 No

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code



250IU

permit & market standing certificate submitted for D01053- Pregabalin Tab 75mg

3) Notary attested copy of valid renewal certificate of manufacturing licenses not submitted.

4) Strength is different in the bid offer form (Anx II), product permit and market standing certificate submitted for D22025- Calcium Carbonate + VitaminD3 Suspension 200 mg +200IU,100ml bottle.

5) Tendered monograph specification not mentioned in the product permit submitted for D02057- Cefpodoxime Proxetil Tab IP 200 mg.


D02093- Azithromycin Oral Suspension IP 200mg/5ml, 30ml bottle

D02057- Cefpodoxime Proxetil Tab IP 200 mg

D01014- Mefenamic Acid Tab BP 500 mg

7) Notary attested copy of Performance statement in Annexure IV not submitted for D01014- Mefenamic Acid Tab BP 500 mg.

8) Notary attested copy of Product permit not submitted for D13059- Ramipril Tab IP 5mg.

5. D02057 CEFPODOXIME PROXETIL TAB IP 200 mg 1 No.


7. D12002 FOLIC ACID TAB IP 5 mg 1 No.

8. D20015 LACTULOSE SOLUTION USP 667 mg/ ml 100ml bottle

9. D01014 MEFENAMIC ACID TAB BP 500 mg 1 No.

10. D05029 MONTELUKAST TAB IP 10 mg 1 No.

11. D01003 PARACETAMOL PAEDIATRIC SYRUP/SUSPENSION IP 125 mg/5ml

60ml Bottle

12. D01053 PREGABALIN TAB 75 mg 1 No.

13. D13059 RAMIPRIL TAB IP 5 mg 1 No.

14. D13061 TELMISARTAN TAB IP 40 mg 1 No.

15. D20037 URSODEOXYCHOLIC ACID TAB IP 300 mg 1 No.

Bid No. 86 M/s. Aishwarya Health Care, HP

1. D15022 CARBOXY

METHYLCELLULOSE EYE DROPS IP

0.50% 10ml 1) Bid offer form (Anx II), Product

permit and Market standing

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code



0.3%w/v 5ml Bottle Certificate submitted for D15071- Oxymetazoline Hydrochloride Nasal Solution (Paediatric) IP 0.025% w/v, 10ml is in “USP” instead of “IP” specification.

2) Pack size is mentioned as “20ml” instead of the tendered specification of “15ml” in the bid offer form (Anx II) submitted for D15011- Saline Nasal Drops 0.65%w/v, 15ml Bot.

3. D18010 MANNITOL INJ IP 20%w/v 100ml Bot


0.50% 5 ml

5. D02018 OFLOXACIN INFUSION IP 2 mg/ml 100ml Bot

6. D15071 OXYMETAZOLINE

HYDROCHLORIDE NASAL SOLUTION (PAEDIATRIC ) IP

0.025% w/v 10ml

7. D01035 PARACETAMOL INFUSION

IP 1gm/100ml 100ml Bottle

8. D15011 SALINE NASAL DROPS 0.65%w/v 15ml Bot

9. D15009 XYLOMETAZOLINE NASAL DROPS IP 0.1% w/v 10 ml Bottle

Bid No. 87 M/s. Hetero Labs Limited, Hyderabad

1. D13013 ATORVASTATIN TAB IP 10 mg 1 No 1) Market standing certificate not

submitted for the following;

D02055- Cefixime Tab IP 200 mg

D02078- Linezolid Tab IP 600 mg

2) Certificate to prove 3 year market standing not submitted for the following;

D02031- Azithromycin Tab IP 500mg

D09007- Oseltamivir Cap IP 75 mg

3) Tendered monograph specification not mentioned in the product permit submitted for D02055- Cefixime Tab IP 200 mg.

4) Date of manufacturing not mentioned in the performance statement (Anx IV) submitted for D09007- Oseltamivir Cap IP 75 mg.





6. D20021 RABEPRAZOLE GASTRO RESISTANT TAB IP 20 mg 1 No

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


Bid No. 88 M/s. Kerala State Drugs and Pharmaceuticals Ltd.

Kerala State Public Sector Undertaking

Bid No. 89 M/s. VHB Medi Sciences Limited, Mumbai

1. D12003 HEPARIN SODIUM INJ IP 5000 IU/ ml 5 ml Vial Submitted the required documents.


40 mg/ 0.4 ml Vial/PFS

Bid No. 90 M/s. Systa Pharma Labs Private Limited, Thrissur

1. D02031 AZITHROMYCIN TAB IP 500 mg 1No Submitted the required documents.

2. D20021 RABEPRAZOLE (GASTRO RESISTANT) TAB IP

20 mg 1No

3. D12002 FOLIC ACID TAB IP 5 mg 1No

4. D20033

PANTOPRAZOLE (GASTRO RESISTANT) TAB IP 40 mg 1 No

Bid No. 91 M/s. Medipol Pharmaceuticals India Pvt. Ltd, New Delhi



D02098-Clindamycin+ ClotrimazoleVaginal Pessary 100mg+200 mg

D01053- Pregabalin Tab 75 mg

D18015- Potassium Citrate Solution 200 ml

2) Notary attested copy of Performance statement in Annexure IV not submitted for D02098- Clindamycin+ Clotrimazole Vaginal Pessary 100mg+200 mg

3) Cross condition for the supply of item noted in page no.12 of the online bid to limit the supplies at a single location will

2. D16022 PROSTAGLANDIN E2 GEL 0.5 mg 3.0 gm tube

3. D02098 CLINDAMYCIN +

CLOTRIMAZOLE VAGINAL PESSARY

100 mg+200 mg 1 No



200 ml

5. D01053 PREGABALIN TAB 75 mg 1no

6. D18018 POTASSIUM CHLORIDE ORAL SOLUTION USP

10% 100 ml

7. D22033 THIAMINE TAB IP

100 mg 1 NO

…………………………………………………………………………………………………………………………………………………………………………………………………….


Sl. No

Drug Code


not be accepted.

Sd/- MANAGING DIRECTOR (I/C)

KERALA MEDICAL SERVICES CORPORATION LTD. (TENDER INVITING AUTHORITY)

KERALA MEDICAL SERVICES CORPORATION LTD., I and II Final-first notic… · EAR DROPS BP 10 ml Bottle 7. D25002 SURGICAL SPIRIT IP 500 ml Bottle 8. D14027 TURPENTINE LINIMENT IP 100

Documents